#  @McFlusion McFlusion McFlusion posts on X about novartis, $abbv, sanofi, eli lilly the most. They currently have [-------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours. ### Engagements: [-----] [#](/creator/twitter::393073854/interactions)  - [--] Week [---] +130% - [--] Month [-----] +60% - [--] Months [-----] +123% - [--] Year [------] +320% ### Mentions: [--] [#](/creator/twitter::393073854/posts_active)  - [--] Week [--] +95% - [--] Month [--] +75% - [--] Months [---] +91% - [--] Year [---] +287% ### Followers: [-------] [#](/creator/twitter::393073854/followers)  - [--] Week [--] no change - [--] Month [--] no change - [--] Months [--] +2.10% - [--] Year [--] +33% ### CreatorRank: undefined [#](/creator/twitter::393073854/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [countries](/list/countries) [technology brands](/list/technology-brands) [travel destinations](/list/travel-destinations) [us election](/list/us-election) [currencies](/list/currencies) [vc firms](/list/vc-firms) [celebrities](/list/celebrities) [automotive brands](/list/automotive-brands) **Social topic influence** [novartis](/topic/novartis), [$abbv](/topic/$abbv) #85, [sanofi](/topic/sanofi), [eli lilly](/topic/eli-lilly), [novo](/topic/novo), [investment](/topic/investment), [rfk](/topic/rfk), [$1b](/topic/$1b), [pharma](/topic/pharma), [acquisition](/topic/acquisition) **Top accounts mentioned or mentioned by** [@fwpharma](/creator/undefined) [@fwhealthtech](/creator/undefined) [@statnews](/creator/undefined) [@biopharmadive](/creator/undefined) [@pharmatechfocus](/creator/undefined) [@lmtonline](/creator/undefined) [@qz](/creator/undefined) [@investopedia](/creator/undefined) [@yahoonews](/creator/undefined) [@pharmavoice](/creator/undefined) [@barronsonline](/creator/undefined) [@medtechdive](/creator/undefined) [@sfgate](/creator/undefined) [@drmakaryfda](/creator/undefined) [@seckennedy](/creator/undefined) **Top assets mentioned** [Novartis AG (NVS)](/topic/novartis) [AbbVie Inc (ABBV)](/topic/$abbv) [Sanofi (SNY)](/topic/sanofi) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Pfizer, Inc. (PFE)](/topic/pfizer) [Merck & Co., Inc. (MRK)](/topic/merck) [CVS Health Corp (CVS)](/topic/cvs) [GSK plc (GSK)](/topic/gsk-plc) ### Top Social Posts Top posts by engagements in the last [--] hours "Astellas hit by US patent verdict for incontinence drug" [X Link](https://x.com/McFlusion/status/1668579151698186240) 2023-06-13T11:20Z [--] followers, [--] engagements "AbbVie Removes Two Early-Stage Cancer Assets from Pipeline BioSpace #jobs" [X Link](https://x.com/McFlusion/status/1696113369793606039) 2023-08-28T10:51Z [--] followers, [--] engagements "British drugmaker GSK Plc said on Friday the U.S. Food and Drug Administration had approved its experimental oral therapy to treat anemia in patients with a type of bone marrow cancer called myelofibrosis" [X Link](https://x.com/McFlusion/status/1703698721374916883) 2023-09-18T09:13Z [--] followers, [--] engagements "We will be exhibiting on the [----] ISPE Annual Meeting & Expo in Las Vegas on Oct. 16-18. Connect with us at booth #927 in the Shoreline Exhibit Hall. Click here to visit our online showroom:" [X Link](https://x.com/McFlusion/status/1711744139421737104) 2023-10-10T14:03Z [--] followers, [--] engagements "Illumina to Divest Cancer Test Maker Grail if It Loses US or EU Court Appeal" [X Link](https://x.com/McFlusion/status/1712426433878867999) 2023-10-12T11:14Z [--] followers, [--] engagements "Novo Nordisk to buy hypertension drug from KBP Biosciences for $1.3 billion via @fwpharma https://firstwordpharma.com/story/5789945 https://firstwordpharma.com/story/5789945" [X Link](https://x.com/McFlusion/status/1713894165480886758) 2023-10-16T12:26Z [--] followers, [--] engagements "Brand-new $112 million life sciences hub opens in The Woodlands via @lmtonline" [X Link](https://x.com/McFlusion/status/1715371448628347088) 2023-10-20T14:16Z [--] followers, [--] engagements "Fast-growing Samsung Biologics chided by FDA over shortfalls at plant in Korea" [X Link](https://x.com/McFlusion/status/1716796757168759288) 2023-10-24T12:40Z [--] followers, [--] engagements "Fresenius Medical Care Recalls Some Hemodialysis Machines for Potential Exposure to Toxic Compounds https://www.fda.gov/medical-devices/medical-device-recalls/fresenius-medical-care-recalls-some-hemodialysis-machines-potential-exposure-toxic-compounds https://www.fda.gov/medical-devices/medical-device-recalls/fresenius-medical-care-recalls-some-hemodialysis-machines-potential-exposure-toxic-compounds" [X Link](https://x.com/McFlusion/status/1717137910682562950) 2023-10-25T11:15Z [--] followers, [--] engagements "Amgen plans to lay off [---] former Horizon employees after $28B buyout" [X Link](https://x.com/McFlusion/status/1717138455317065896) 2023-10-25T11:18Z [--] followers, [--] engagements "Cipla Limited - [------] - 11/17/2023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023" [X Link](https://x.com/McFlusion/status/1727321316301078722) 2023-11-22T13:41Z [--] followers, [--] engagements "Veteran Big Pharma chief lashes out at Tucker Carlson Elon Musks drug ad criticism on X" [X Link](https://x.com/McFlusion/status/1731999598502166973) 2023-12-05T11:30Z [--] followers, [--] engagements "Cipla Limited - [------] - 11/17/2023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023" [X Link](https://x.com/McFlusion/status/1732400654809759756) 2023-12-06T14:04Z [--] followers, [--] engagements "Cipla Limited - [------] - 11/17/2023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023" [X Link](https://x.com/McFlusion/status/1734926741255102677) 2023-12-13T13:22Z [--] followers, [--] engagements "Olympus Corporation of the Americas Recalls Bronchofiberscopes and Bronchovideoscopes Because They Can Lead to Burns and Fire" [X Link](https://x.com/McFlusion/status/1737433487844503632) 2023-12-20T11:23Z [--] followers, [--] engagements "Philips North America LLC Recalls Panorama 1.0T HFO due to a Risk of Explosion During a Quench Procedure Caused by Excessive Pressure Buildup of Helium Gas" [X Link](https://x.com/McFlusion/status/1737546219751104999) 2023-12-20T18:51Z [--] followers, [--] engagements "Cipla Limited - [------] - 11/17/2023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023" [X Link](https://x.com/McFlusion/status/1737546549473722870) 2023-12-20T18:52Z [--] followers, [--] engagements "Novo Nordisk submits application for massive manufacturing campus near Dublin" [X Link](https://x.com/McFlusion/status/1742082091217486207) 2024-01-02T07:15Z [--] followers, [--] engagements "BMS enters radiopharma race with $4.1B acquisition of RayzeBio just [--] months after biotech went public" [X Link](https://x.com/McFlusion/status/1742082738813841675) 2024-01-02T07:17Z [--] followers, [--] engagements "An attractive opportunity for investing: Goldman Sachs closes $650M fund aimed at biotechs" [X Link](https://x.com/McFlusion/status/1742808569194365239) 2024-01-04T07:21Z [--] followers, [--] engagements "Merck & Co. looks to snare Harpoon with $700-million bid: report via @fwpharma" [X Link](https://x.com/McFlusion/status/1744303508063408533) 2024-01-08T10:22Z [--] followers, [--] engagements "AbbVie launches pump-based Parkinsons drug in EU" [X Link](https://x.com/McFlusion/status/1745453447095398632) 2024-01-11T14:31Z [--] followers, [--] engagements "Merck & Co. signs $220M macrocyclic peptide deal after hailing next wave of drug discovery https://www.fiercebiotech.com/biotech/merck-co-signs-220m-macrocyclic-peptide-deal-after-hailing-next-wave-drug-discovery https://www.fiercebiotech.com/biotech/merck-co-signs-220m-macrocyclic-peptide-deal-after-hailing-next-wave-drug-discovery" [X Link](https://x.com/McFlusion/status/1750129914093662400) 2024-01-24T12:14Z [--] followers, [--] engagements "Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33% https://www.channelnewsasia.com/business/gilead-sciences-raises-stake-cancer-centric-arcus-biosciences-33-4084126 https://www.channelnewsasia.com/business/gilead-sciences-raises-stake-cancer-centric-arcus-biosciences-33-4084126" [X Link](https://x.com/McFlusion/status/1752326387439177801) 2024-01-30T13:42Z [--] followers, [--] engagements "White House wins in first Medicare negotiation legal ruling" [X Link](https://x.com/McFlusion/status/1757386035430879589) 2024-02-13T12:47Z [--] followers, [--] engagements "As Catalent moves toward Novo buyout its restructuring claimed [---] jobs last year" [X Link](https://x.com/McFlusion/status/1758182424205279601) 2024-02-15T17:32Z [--] followers, [--] engagements "Novo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug results" [X Link](https://x.com/McFlusion/status/1762806365641200095) 2024-02-28T11:46Z [--] followers, [--] engagements "Novo Nordisk's amycretin outshines Wegovy in early obesity study via @fwpharma" [X Link](https://x.com/McFlusion/status/1765777091478294695) 2024-03-07T16:30Z [--] followers, [--] engagements "After Kyowa Kirin buyout Orchard scores FDA approval for first MLD gene therapy in the US" [X Link](https://x.com/McFlusion/status/1770004034604167554) 2024-03-19T08:27Z [--] followers, [--] engagements "Sanders Blasts Novo Nordisk for Outrageous Price of Ozempic Wegovy BioSpace #jobs https://www.biospace.com/article/sanders-blasts-novo-nordisk-for-outrageous-price-of-ozempic-wegovy/utm_source=socialmedia https://www.biospace.com/article/sanders-blasts-novo-nordisk-for-outrageous-price-of-ozempic-wegovy/utm_source=socialmedia" [X Link](https://x.com/McFlusion/status/1773379520869097701) 2024-03-28T16:00Z [--] followers, [--] engagements "Novo Nordisk triumphs in UK probe of 'hyperbolic' Wegovy claims https://www.fiercepharma.com/marketing/novo-nordisk-triumphs-uk-probe-hyperbolic-wegovy-claims https://www.fiercepharma.com/marketing/novo-nordisk-triumphs-uk-probe-hyperbolic-wegovy-claims" [X Link](https://x.com/McFlusion/status/1775563886080426491) 2024-04-03T16:39Z [--] followers, [--] engagements "Aruba Aloe Balm N.V. Issues Voluntary Nationwide Recall of Aruba Aloe Hand Sanitizer Gel Alcohol 80% and Aruba Aloe Alcoholada Gel Due to Presence of Methanol https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aruba-aloe-balm-nv-issues-voluntary-nationwide-recall-aruba-aloe-hand-sanitizer-gel-alcohol-80-and https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aruba-aloe-balm-nv-issues-voluntary-nationwide-recall-aruba-aloe-hand-sanitizer-gel-alcohol-80-and" [X Link](https://x.com/McFlusion/status/1777668515689910616) 2024-04-09T12:02Z [--] followers, [--] engagements "Eli Lilly to acquire manufacturing facility from Nexus Pharma https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-manufacturing-facility-nexus-pharma-2024-04-22/ https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-manufacturing-facility-nexus-pharma-2024-04-22/" [X Link](https://x.com/McFlusion/status/1782743768896069903) 2024-04-23T12:10Z [--] followers, [--] engagements "Supreme Court Denies Vandas Petition in Hetlioz Patent Case Against Teva BioSpace #jobs https://www.biospace.com/article/supreme-court-denies-vanda-s-petition-in-hetlioz-patent-case-against-teva-/utm_source=socialmedia https://www.biospace.com/article/supreme-court-denies-vanda-s-petition-in-hetlioz-patent-case-against-teva-/utm_source=socialmedia" [X Link](https://x.com/McFlusion/status/1782744311164985645) 2024-04-23T12:12Z [--] followers, [--] engagements "Sanofi pulls off phase [--] LUNA landing sparking race to regulators for BTK inhibitor https://www.fiercebiotech.com/biotech/sanofi-pulls-phase-3-luna-landing-sparking-race-regulators-btk-inhibitor https://www.fiercebiotech.com/biotech/sanofi-pulls-phase-3-luna-landing-sparking-race-regulators-btk-inhibitor" [X Link](https://x.com/McFlusion/status/1783099873539072041) 2024-04-24T11:45Z [--] followers, [--] engagements "Weight-loss drug drives Eli Lilly to raise [----] sales forecast by $2 billion https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-beats-profit-estimates-diabetes-weight-loss-drug-strength-2024-04-30/ https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-beats-profit-estimates-diabetes-weight-loss-drug-strength-2024-04-30/" [X Link](https://x.com/McFlusion/status/1785619429436350489) 2024-05-01T10:37Z [--] followers, [--] engagements "Tandem Diabetes Care Inc. Recalls Version [---] of the Apple iOS t:connect Mobile App Used in Conjunction with t:slim X2 Insulin Pump with Control-IQ Technology Prompted by a Software Problem Leading to Pump Battery Depletion https://www.fda.gov/medical-devices/medical-device-recalls/tandem-diabetes-care-inc-recalls-version-27-apple-ios-tconnect-mobile-app-used-conjunction-tslim-x2 https://www.fda.gov/medical-devices/medical-device-recalls/tandem-diabetes-care-inc-recalls-version-27-apple-ios-tconnect-mobile-app-used-conjunction-tslim-x2" [X Link](https://x.com/McFlusion/status/1788543921280168018) 2024-05-09T12:17Z [--] followers, [--] engagements "Johnson & Johnson looks to offload remaining Kenvue stake in $3.75B deal https://www.fiercepharma.com/pharma/johnson-johnson-looks-offload-remaining-kenvue-stake-375b-deal https://www.fiercepharma.com/pharma/johnson-johnson-looks-offload-remaining-kenvue-stake-375b-deal" [X Link](https://x.com/McFlusion/status/1790076331000017251) 2024-05-13T17:47Z [--] followers, [--] engagements "Philips Respironics Inc. Recalls Trilogy Evo Continuous Ventilators due to a Software-Related Possible Power Malfunction https://www.fda.gov/medical-devices/medical-device-recalls/philips-respironics-inc-recalls-trilogy-evo-continuous-ventilators-due-software-related-possible https://www.fda.gov/medical-devices/medical-device-recalls/philips-respironics-inc-recalls-trilogy-evo-continuous-ventilators-due-software-related-possible" [X Link](https://x.com/McFlusion/status/1790076376143327508) 2024-05-13T17:47Z [--] followers, [--] engagements "Sanders Warns Weight-Loss Drugs Could Bankrupt US Healthcare System BioSpace #jobs https://www.biospace.com/article/sanders-warns-weight-loss-drugs-could-bankrupt-us-healthcare-system/utm_source=socialmedia https://www.biospace.com/article/sanders-warns-weight-loss-drugs-could-bankrupt-us-healthcare-system/utm_source=socialmedia" [X Link](https://x.com/McFlusion/status/1791134684841181282) 2024-05-16T15:52Z [--] followers, [--] engagements "Hologic Inc. Recalls BioZorb Marker Due to Complications with Implanted Devices https://www.fda.gov/medical-devices/medical-device-recalls/hologic-inc-recalls-biozorb-marker-due-complications-implanted-devices https://www.fda.gov/medical-devices/medical-device-recalls/hologic-inc-recalls-biozorb-marker-due-complications-implanted-devices" [X Link](https://x.com/McFlusion/status/1793598243038765215) 2024-05-23T11:01Z [--] followers, [--] engagements "US FDA panel votes against Novo Nordisk's weekly insulin in type [--] diabetes patients https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-against-use-novo-nordisks-weekly-insulin-type-1-diabetes-2024-05-24/ https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-against-use-novo-nordisks-weekly-insulin-type-1-diabetes-2024-05-24/" [X Link](https://x.com/McFlusion/status/1795401975330185425) 2024-05-28T10:29Z [--] followers, [--] engagements "Mexican man dies in first human case of H5N2 bird flu https://pharmaphorum.com/news/mexican-man-dies-first-human-case-h5n2-bird-flu https://pharmaphorum.com/news/mexican-man-dies-first-human-case-h5n2-bird-flu" [X Link](https://x.com/McFlusion/status/1798687288219902098) 2024-06-06T12:04Z [--] followers, [--] engagements "AbbVie's tight grip on Humira market raises concerns about biosimilars https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-tight-grip-humira-market-raises-concerns-about-biosimilars-2024-06-07/ https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-tight-grip-humira-market-raises-concerns-about-biosimilars-2024-06-07/" [X Link](https://x.com/McFlusion/status/1800124129275675121) 2024-06-10T11:13Z [--] followers, [--] engagements "Novo Nordisk CEO agrees to testify on semaglutide pricing https://pharmaphorum.com/news/novo-nordisk-ceo-agrees-testify-semaglutide-pricing https://pharmaphorum.com/news/novo-nordisk-ceo-agrees-testify-semaglutide-pricing" [X Link](https://x.com/McFlusion/status/1803066476363980903) 2024-06-18T14:05Z [--] followers, [--] engagements "FDA Action Alert: Merck Verona AbbVie and Rocket BioSpace #jobs https://www.biospace.com/article/fda-action-alert-merck-verona-abbvie-and-rocket/utm_source=socialmedia https://www.biospace.com/article/fda-action-alert-merck-verona-abbvie-and-rocket/utm_source=socialmedia" [X Link](https://x.com/McFlusion/status/1805188567334863353) 2024-06-24T10:37Z [--] followers, [--] engagements "Major plans for South Dublin pharma plant cancelled https://www.fm104.ie/news/fm104-news/major-plans-for-south-dublin-pharma-plant-cancelled/ https://www.fm104.ie/news/fm104-news/major-plans-for-south-dublin-pharma-plant-cancelled/" [X Link](https://x.com/McFlusion/status/1805192828181500163) 2024-06-24T10:54Z [--] followers, [--] engagements "Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing - https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-maker-novo-nordisk-spend-41-bln-boost-us-manufacturing-2024-06-24/ https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-maker-novo-nordisk-spend-41-bln-boost-us-manufacturing-2024-06-24/" [X Link](https://x.com/McFlusion/status/1805521197733392549) 2024-06-25T08:39Z [--] followers, [--] engagements "FDA Again Hits AbbVie Parkinsons Treatment With Complete Response Letter BioSpace #jobs https://www.biospace.com/article/fda-again-hits-abbvie-parkinson-s-treatment-with-crl-/utm_source=socialmedia https://www.biospace.com/article/fda-again-hits-abbvie-parkinson-s-treatment-with-crl-/utm_source=socialmedia" [X Link](https://x.com/McFlusion/status/1805627821634863408) 2024-06-25T15:43Z [--] followers, [--] engagements "FDA Again Hits AbbVie Parkinsons Treatment With Complete Response Letter BioSpace #jobs https://www.biospace.com/article/fda-again-hits-abbvie-parkinson-s-treatment-with-crl-/utm_source=socialmedia https://www.biospace.com/article/fda-again-hits-abbvie-parkinson-s-treatment-with-crl-/utm_source=socialmedia" [X Link](https://x.com/McFlusion/status/1805918473966571685) 2024-06-26T10:58Z [--] followers, [--] engagements "Supreme Court Rejects Purdues Opioid Pact With Sackler Shield https://www.bloomberg.com/news/articles/2024-06-27/supreme-court-rejects-purdue-s-opioid-pact-with-sackler-shield https://www.bloomberg.com/news/articles/2024-06-27/supreme-court-rejects-purdue-s-opioid-pact-with-sackler-shield" [X Link](https://x.com/McFlusion/status/1806331918914330805) 2024-06-27T14:21Z [--] followers, [--] engagements "AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave https://www.fiercebiotech.com/biotech/abbvie-sweeps-celsius-therapeutics-250m-summer-heat-wave https://www.fiercebiotech.com/biotech/abbvie-sweeps-celsius-therapeutics-250m-summer-heat-wave" [X Link](https://x.com/McFlusion/status/1806676575150117245) 2024-06-28T13:10Z [--] followers, [--] engagements "Merck's Capvaxive gears up to challenge Pfizer's dominant Prevnar with CDC panel backing https://www.fiercepharma.com/pharma/mercks-new-capvaxive-ready-challenge-pfizers-dominant-prevnar-cdc-panel-endorsement https://www.fiercepharma.com/pharma/mercks-new-capvaxive-ready-challenge-pfizers-dominant-prevnar-cdc-panel-endorsement" [X Link](https://x.com/McFlusion/status/1806736496268808261) 2024-06-28T17:08Z [--] followers, [--] engagements "Novo Nordisk Partners With BE&K For Facility Expansion In Clayton NC Contract Pharma https://www.contractpharma.com/contents/view_breaking-news/2024-06-28/novo-nordisk-partners-with-bek-for-facility-expansion-in-clayton-nc/ https://www.contractpharma.com/contents/view_breaking-news/2024-06-28/novo-nordisk-partners-with-bek-for-facility-expansion-in-clayton-nc/" [X Link](https://x.com/McFlusion/status/1810259358946623609) 2024-07-08T10:27Z [--] followers, [--] engagements "Generic-Viagra Safety Called Into Doubt After False Data Found by FDA https://www.bloomberg.com/news/articles/2024-07-09/generic-viagra-cialis-lipitor-safety-in-question-after-fda-finds-false-data https://www.bloomberg.com/news/articles/2024-07-09/generic-viagra-cialis-lipitor-safety-in-question-after-fda-finds-false-data" [X Link](https://x.com/McFlusion/status/1810624111216914484) 2024-07-09T10:36Z [--] followers, [--] engagements "An Implantable Hypoglossal Nerve Stimulator Device Removal: Inspire Medical Systems Inc. Removes Inspire IV Implantable Pulse Generator due to Manufacturing Defect That Can Result in System Malfunctions https://www.fda.gov/medical-devices/medical-device-recalls/implantable-hypoglossal-nerve-stimulator-device-removal-inspire-medical-systems-inc-removes-inspire https://www.fda.gov/medical-devices/medical-device-recalls/implantable-hypoglossal-nerve-stimulator-device-removal-inspire-medical-systems-inc-removes-inspire" [X Link](https://x.com/McFlusion/status/1810629677368705160) 2024-07-09T10:58Z [--] followers, [--] engagements "PBMs Wield Enormous Power Over Patient Access to Affordable Drugs: FTC BioSpace #jobs https://www.biospace.com/article/ftc-report-finds-pharmacy-benefit-managers-wield-enormous-power-over-patient-access-to-affordable-drugs/utm_source=socialmedia https://www.biospace.com/article/ftc-report-finds-pharmacy-benefit-managers-wield-enormous-power-over-patient-access-to-affordable-drugs/utm_source=socialmedia" [X Link](https://x.com/McFlusion/status/1810703864846254160) 2024-07-09T15:53Z [--] followers, [--] engagements "FDA rejects Novo Nordisks weekly basal insulin https://pharmaphorum.com/news/fda-rejects-novo-nordisks-weekly-basal-insulin https://pharmaphorum.com/news/fda-rejects-novo-nordisks-weekly-basal-insulin" [X Link](https://x.com/McFlusion/status/1811381911027065271) 2024-07-11T12:47Z [--] followers, [--] engagements "Novo Nordisk upset as Dutch agency advises against insurance cover for Wegovy https://www.reuters.com/business/healthcare-pharmaceuticals/dutch-government-should-not-subsidise-weight-loss-drug-wegovy-adviser-says-2024-07-17/ https://www.reuters.com/business/healthcare-pharmaceuticals/dutch-government-should-not-subsidise-weight-loss-drug-wegovy-adviser-says-2024-07-17/" [X Link](https://x.com/McFlusion/status/1813902941729821005) 2024-07-18T11:45Z [--] followers, [--] engagements "HCL Injection (400mcg/100mL) https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-one-lot-acetaminophen-injection https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-one-lot-acetaminophen-injection" [X Link](https://x.com/McFlusion/status/1815706590181278124) 2024-07-23T11:12Z [--] followers, [--] engagements "Biopharma Layoff Tracker 2024: Pfizer Cue Anokion and More Cut Staff https://www.biospace.com/biospace-layoff-tracker https://www.biospace.com/biospace-layoff-tracker" [X Link](https://x.com/McFlusion/status/1818588413706076536) 2024-07-31T10:04Z [--] followers, [--] engagements "Listerine maker Kenvue beats estimates on strong essential health product sales - https://www.reuters.com/business/healthcare-pharmaceuticals/listerine-maker-kenvue-beats-estimates-strong-essential-health-product-sales-2024-08-06/ https://www.reuters.com/business/healthcare-pharmaceuticals/listerine-maker-kenvue-beats-estimates-strong-essential-health-product-sales-2024-08-06/" [X Link](https://x.com/McFlusion/status/1820777683120218571) 2024-08-06T11:03Z [--] followers, [--] engagements "Japanese medical equipment company to invest $398M create [---] jobs in Greenville https://www.ncbiotech.org/news/japanese-medical-equipment-company-invest-398m-create-232-jobs-greenville https://www.ncbiotech.org/news/japanese-medical-equipment-company-invest-398m-create-232-jobs-greenville" [X Link](https://x.com/McFlusion/status/1820845638692507792) 2024-08-06T15:33Z [--] followers, [--] engagements "Bavarian Nordic scores $157M contract to replenish US supplies of smallpox/mpox vaccine Jynneos https://www.fiercepharma.com/pharma/bavarian-nordic-scores-1568m-contract-replenish-us-supplies-combination-smallpoxmpox-vaccine https://www.fiercepharma.com/pharma/bavarian-nordic-scores-1568m-contract-replenish-us-supplies-combination-smallpoxmpox-vaccine" [X Link](https://x.com/McFlusion/status/1821841632846606347) 2024-08-09T09:31Z [--] followers, [--] engagements "After icodec rejection Novo Nordisk plots [----] FDA filing for once-weekly insulin and semaglutide combo https://www.fiercepharma.com/pharma/after-icodec-rejection-novo-nordisk-plots-2024-fda-filing-once-weekly-insulin-and https://www.fiercepharma.com/pharma/after-icodec-rejection-novo-nordisk-plots-2024-fda-filing-once-weekly-insulin-and" [X Link](https://x.com/McFlusion/status/1823293748249243701) 2024-08-13T09:41Z [--] followers, [--] engagements "Amgen sues Samsung biotech unit over bone drug copies - https://www.reuters.com/legal/litigation/amgen-sues-samsung-biotech-unit-over-bone-drug-copies-2024-08-13/ https://www.reuters.com/legal/litigation/amgen-sues-samsung-biotech-unit-over-bone-drug-copies-2024-08-13/" [X Link](https://x.com/McFlusion/status/1823702461263053175) 2024-08-14T12:45Z [--] followers, [--] engagements "Tandem Diabetes Care Provides Update on March [----] Nationwide Recall of t:connect Mobile App for iOS Devices https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/tandem-diabetes-care-provides-update-march-2024-nationwide-recall-tconnect-mobile-app-ios-devices https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/tandem-diabetes-care-provides-update-march-2024-nationwide-recall-tconnect-mobile-app-ios-devices" [X Link](https://x.com/McFlusion/status/1823703793441116368) 2024-08-14T12:50Z [--] followers, [--] engagements "Why is mpox an emergency again and how worried should I be https://www.reuters.com/business/healthcare-pharmaceuticals/why-is-mpox-an-emergency-again-how-worried-should-i-be-2024-08-15/ https://www.reuters.com/business/healthcare-pharmaceuticals/why-is-mpox-an-emergency-again-how-worried-should-i-be-2024-08-15/" [X Link](https://x.com/McFlusion/status/1824034074001871333) 2024-08-15T10:43Z [--] followers, [--] engagements "IRA negotiated prices revealed as Biden claims $6bn savings https://pharmaphorum.com/news/ira-negotiated-prices-revealed-biden-claims-6bn-savings https://pharmaphorum.com/news/ira-negotiated-prices-revealed-biden-claims-6bn-savings" [X Link](https://x.com/McFlusion/status/1824388438763725255) 2024-08-16T10:11Z [--] followers, [--] engagements "Avantor sells clinical services unit to private equity firm for $650M https://www.fiercebiotech.com/cro/avantor-sells-clinical-services-unit-private-equity-firm-650m https://www.fiercebiotech.com/cro/avantor-sells-clinical-services-unit-private-equity-firm-650m" [X Link](https://x.com/McFlusion/status/1825842796546154751) 2024-08-20T10:30Z [--] followers, [--] engagements "Infusion Pump Battery Correction: ICU Medical Updates Instructions for Use Regarding Batteries in Plum [---] A+ and A+3 Infusion System due to Diminished Battery Life that May Impact Infusion Delivery https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-battery-correction-icu-medical-updates-instructions-use-regarding-batteries-plum-360 https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-battery-correction-icu-medical-updates-instructions-use-regarding-batteries-plum-360" [X Link](https://x.com/McFlusion/status/1826291940679446551) 2024-08-21T16:15Z [--] followers, [--] engagements "Infusion Pump Battery Correction: ICU Medical Updates Instructions for Use Regarding Batteries in Plum [---] A+ and A+3 Infusion System due to Diminished Battery Life that May Impact Infusion Delivery https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-battery-correction-icu-medical-updates-instructions-use-regarding-batteries-plum-360 https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-battery-correction-icu-medical-updates-instructions-use-regarding-batteries-plum-360" [X Link](https://x.com/McFlusion/status/1826578003481989255) 2024-08-22T11:11Z [--] followers, [--] engagements "Cigna to Remove AbbVies Humira From Formularies Putting More Pressure on Blockbuster https://www.biospace.com/business/cigna-to-remove-abbvies-humira-from-formularies-putting-more-pressure-on-blockbuster https://www.biospace.com/business/cigna-to-remove-abbvies-humira-from-formularies-putting-more-pressure-on-blockbuster" [X Link](https://x.com/McFlusion/status/1828467431175581782) 2024-08-27T16:19Z [--] followers, [--] engagements "AstraZeneca investment to increase biologic capacity in Sweden https://www.europeanpharmaceuticalreview.com/news/232693/astrazeneca-investment-to-increase-biologic-capacity-in-sweden/ https://www.europeanpharmaceuticalreview.com/news/232693/astrazeneca-investment-to-increase-biologic-capacity-in-sweden/" [X Link](https://x.com/McFlusion/status/1828754273821462612) 2024-08-28T11:19Z [--] followers, [--] engagements "AGC Biologics Receives FDA Approval for Biosimilar at Copenhagen Facility https://www.citybuzz.co/2024/08/28/agc-biologics-receives-fda-approval-for-biosimilar-at-copenhagen-facility/ https://www.citybuzz.co/2024/08/28/agc-biologics-receives-fda-approval-for-biosimilar-at-copenhagen-facility/" [X Link](https://x.com/McFlusion/status/1829115048624628062) 2024-08-29T11:13Z [--] followers, [--] engagements "FDA warns consumers not to purchase or use Umary and Amazy products as they may be harmful to your health https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-umary-and-amazy-products-they-may-be-harmful-your-health https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-umary-and-amazy-products-they-may-be-harmful-your-health" [X Link](https://x.com/McFlusion/status/1831999073731129657) 2024-09-06T10:13Z [--] followers, [--] engagements "GSK Builds Nucalas COPD Case With Phase III Win https://www.biospace.com/drug-development/gsk-builds-nucalas-copd-case-with-phase-iii-win https://www.biospace.com/drug-development/gsk-builds-nucalas-copd-case-with-phase-iii-win" [X Link](https://x.com/McFlusion/status/1832081558238367778) 2024-09-06T15:40Z [--] followers, [--] engagements "Novo Nordisk experimental obesity pill has mild-to-moderate side effects in early trial https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-experimental-obesity-pill-has-mild-to-moderate-side-effects-early-2024-09-10/ https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-experimental-obesity-pill-has-mild-to-moderate-side-effects-early-2024-09-10/" [X Link](https://x.com/McFlusion/status/1833822268851454093) 2024-09-11T10:57Z [--] followers, [--] engagements "ESMO: AstraZeneca steps out from Daiichi's shadow posting data on ADC rivals to AbbVie Pfizer https://www.fiercebiotech.com/biotech/astrazeneca-steps-out-daiichis-shadow-posting-data-house-rivals-abbvie-and-pfizer-adcs https://www.fiercebiotech.com/biotech/astrazeneca-steps-out-daiichis-shadow-posting-data-house-rivals-abbvie-and-pfizer-adcs" [X Link](https://x.com/McFlusion/status/1835634722862501981) 2024-09-16T10:59Z [--] followers, [--] engagements "ICU Medical recalls tubes used in tracheostomy due to manufacturing defect https://www.reuters.com/business/healthcare-pharmaceuticals/icu-medical-recalls-tubes-used-tracheostomy-due-manufacturing-defect-2024-09-18/ https://www.reuters.com/business/healthcare-pharmaceuticals/icu-medical-recalls-tubes-used-tracheostomy-due-manufacturing-defect-2024-09-18/" [X Link](https://x.com/McFlusion/status/1836711096339644474) 2024-09-19T10:17Z [--] followers, [--] engagements "Pfizer pulls sickle cell med Oxbryta off market after deaths https://pharmaphorum.com/news/pfizer-pulls-sickle-cell-med-oxbryta-market-after-deaths https://pharmaphorum.com/news/pfizer-pulls-sickle-cell-med-oxbryta-market-after-deaths" [X Link](https://x.com/McFlusion/status/1839239779583402011) 2024-09-26T09:45Z [--] followers, [--] engagements "Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price says CEO - https://www.reuters.com/business/healthcare-pharmaceuticals/slow-progress-pfizers-plan-sell-drugs-low-income-nations-not-for-profit-price-2024-09-26/ https://www.reuters.com/business/healthcare-pharmaceuticals/slow-progress-pfizers-plan-sell-drugs-low-income-nations-not-for-profit-price-2024-09-26/" [X Link](https://x.com/McFlusion/status/1839602086272438595) 2024-09-27T09:44Z [--] followers, [--] engagements "J&J to Invest Over $2 Billion for New Manufacturing Facility in North Carolina https://www.usnews.com/news/top-news/articles/2024-10-01/j-j-to-invest-more-than-2-billion-in-new-manufacturing-facilitysrc=usn_tw https://www.usnews.com/news/top-news/articles/2024-10-01/j-j-to-invest-more-than-2-billion-in-new-manufacturing-facilitysrc=usn_tw" [X Link](https://x.com/McFlusion/status/1841405864051192119) 2024-10-02T09:12Z [--] followers, [--] engagements "Big Pharma's layoff wave in New Jersey rolls on with hundreds of J&J cuts [--] at Bayer https://www.fiercepharma.com/pharma/new-jersey-johnson-johnson-cuts-231-while-bayer-axes-57 https://www.fiercepharma.com/pharma/new-jersey-johnson-johnson-cuts-231-while-bayer-axes-57" [X Link](https://x.com/McFlusion/status/1841408135497408904) 2024-10-02T09:21Z [--] followers, [--] engagements "BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval https://www.fiercepharma.com/pharma/bristol-myers-squibbs-opdivo-joins-perioperative-lung-cancer-treatment-ring-key-fda-approval https://www.fiercepharma.com/pharma/bristol-myers-squibbs-opdivo-joins-perioperative-lung-cancer-treatment-ring-key-fda-approval" [X Link](https://x.com/McFlusion/status/1842234810179174755) 2024-10-04T16:06Z [--] followers, [--] engagements "US' top IV fluid maker Baxter voices uncertainty about recovery timeline at North Carolina facility hit by Helene https://www.fiercepharma.com/pharma/us-top-iv-fluid-maker-baxter-voices-uncertainty-about-recovery-timeline-nc-facility-hit https://www.fiercepharma.com/pharma/us-top-iv-fluid-maker-baxter-voices-uncertainty-about-recovery-timeline-nc-facility-hit" [X Link](https://x.com/McFlusion/status/1843327612602769517) 2024-10-07T16:28Z [--] followers, [--] engagements "Warren calls on FTC to scrutinize Novo Holdings' $16.5B Catalent buyout https://www.fiercepharma.com/pharma/sen-warren-sets-sights-novo-holdings-proposed-165b-catalent-acquisition-deal-nears https://www.fiercepharma.com/pharma/sen-warren-sets-sights-novo-holdings-proposed-165b-catalent-acquisition-deal-nears" [X Link](https://x.com/McFlusion/status/1844683582763041169) 2024-10-11T10:16Z [--] followers, [--] engagements "Philips Respironics Issues Additional Usage Instructions for Trilogy Evo Ventilators Related to Use of In-Line Nebulizers https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/philips-respironics-issues-additional-usage-instructions-trilogy-evo-ventilators-related-use-line https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/philips-respironics-issues-additional-usage-instructions-trilogy-evo-ventilators-related-use-line" [X Link](https://x.com/McFlusion/status/1844684285871112504) 2024-10-11T10:19Z [--] followers, [--] engagements "Thermo Fisher plant in North Carolina flagged for contamination air bubble issues in FDA inspection https://www.fiercepharma.com/manufacturing/thermo-fishers-greenville-nc-plant-was-flagged-contamination-air-bubble-issues-fda https://www.fiercepharma.com/manufacturing/thermo-fishers-greenville-nc-plant-was-flagged-contamination-air-bubble-issues-fda" [X Link](https://x.com/McFlusion/status/1844798093314662554) 2024-10-11T17:51Z [--] followers, [--] engagements "Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout - https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-ceo-remain-charge-contract-drugmaker-after-novo-holdings-buyout-2024-10-21/ https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-ceo-remain-charge-contract-drugmaker-after-novo-holdings-buyout-2024-10-21/" [X Link](https://x.com/McFlusion/status/1848672292680667428) 2024-10-22T10:26Z [--] followers, [--] engagements "Roche Beats Q3 Sales Estimates as CEO Voices Opposition to Novo Holdings Catalent Buyout https://www.biospace.com/business/roche-beats-q3-sales-estimates-as-ceo-voices-opposition-to-novo-holdings-catalent-merger https://www.biospace.com/business/roche-beats-q3-sales-estimates-as-ceo-voices-opposition-to-novo-holdings-catalent-merger" [X Link](https://x.com/McFlusion/status/1849115958431907945) 2024-10-23T15:49Z [--] followers, [--] engagements "AbbVie Doubles Down on Alzheimers With $1.4B Aliada Buy https://www.biospace.com/business/abbvie-doubles-down-on-alzheimers-with-1-4b-aliada-buy https://www.biospace.com/business/abbvie-doubles-down-on-alzheimers-with-1-4b-aliada-buy" [X Link](https://x.com/McFlusion/status/1850927980161519776) 2024-10-28T15:49Z [--] followers, [--] engagements "AbbVie to buy Alzheimer's therapy developer Aliada for $1.4 bln https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-alzheimers-therapy-developer-aliada-therapeutics-14-bln-2024-10-28/ https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-alzheimers-therapy-developer-aliada-therapeutics-14-bln-2024-10-28/" [X Link](https://x.com/McFlusion/status/1850930210218090577) 2024-10-28T15:58Z [--] followers, [--] engagements "WuXi AppTec Remains Resilient Amid Threat from BIOSECURE Act Continues to Attract New Clients https://www.biospace.com/business/wuxi-apptec-remains-resilient-amid-threat-from-biosecure-act-continues-to-attract-new-clients https://www.biospace.com/business/wuxi-apptec-remains-resilient-amid-threat-from-biosecure-act-continues-to-attract-new-clients" [X Link](https://x.com/McFlusion/status/1851285037649444999) 2024-10-29T15:28Z [--] followers, [---] engagements "Update: Use of GE HealthCare EVair and EVair [--] Compressors - Letter to Health Care Providers FDA https://www.fda.gov/medical-devices/letters-health-care-providers/update-use-ge-healthcare-evair-and-evair-03-compressors-letter-health-care-providers https://www.fda.gov/medical-devices/letters-health-care-providers/update-use-ge-healthcare-evair-and-evair-03-compressors-letter-health-care-providers" [X Link](https://x.com/McFlusion/status/1851568084642889898) 2024-10-30T10:13Z [--] followers, [--] engagements "Key Novo Nordisk plant where Wegovy Ozempic made cited by FDA Seeking Alpha https://seekingalpha.com/news/4221254-key-novo-nordisk-plant-where-wegovy-ozempic-made-cited-by-fda https://seekingalpha.com/news/4221254-key-novo-nordisk-plant-where-wegovy-ozempic-made-cited-by-fda" [X Link](https://x.com/McFlusion/status/1851569723076469029) 2024-10-30T10:19Z [--] followers, [--] engagements "Incubator/Warmer Correction: GE Healthcare Updates Use Instructions for Giraffe OmniBed and Giraffe Omnibed CareStation due to Risk of Heater Door Falling and Causing Infant Injury https://www.fda.gov/medical-devices/medical-device-recalls/incubatorwarmer-correction-ge-healthcare-updates-use-instructions-giraffe-omnibed-and-giraffe https://www.fda.gov/medical-devices/medical-device-recalls/incubatorwarmer-correction-ge-healthcare-updates-use-instructions-giraffe-omnibed-and-giraffe" [X Link](https://x.com/McFlusion/status/1852298252734873865) 2024-11-01T10:34Z [--] followers, [--] engagements "Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis https://www.biospace.com/business/novo-nordisk-signs-285m-glp-1-deal-with-danish-neighbor-ascendis https://www.biospace.com/business/novo-nordisk-signs-285m-glp-1-deal-with-danish-neighbor-ascendis" [X Link](https://x.com/McFlusion/status/1853480005566697934) 2024-11-04T16:50Z [--] followers, [--] engagements "Fujifilm Diosynth Biotechnologies Launches First Phase of Expansion in Denmark https://shar.es/ag4fcx https://shar.es/ag4fcx" [X Link](https://x.com/McFlusion/status/1854106482087702738) 2024-11-06T10:20Z [--] followers, [--] engagements "Johnson & Johnson to invest $2B on new biologics facility in Wilson create [---] jobs https://www.ncbiotech.org/news/johnson-johnson-invest-2b-new-biologics-facility-wilson-create-420-jobs https://www.ncbiotech.org/news/johnson-johnson-invest-2b-new-biologics-facility-wilson-create-420-jobs" [X Link](https://x.com/McFlusion/status/1854178698154389987) 2024-11-06T15:07Z [--] followers, [--] engagements "Trump Victory a Modest Positive for Biopharma Industry: Analysts https://www.biospace.com/policy/trump-victory-a-modest-positive-for-biopharma-industry-analysts https://www.biospace.com/policy/trump-victory-a-modest-positive-for-biopharma-industry-analysts" [X Link](https://x.com/McFlusion/status/1854199532596179294) 2024-11-06T16:29Z [--] followers, [--] engagements "Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase [--] fail https://www.fiercebiotech.com/biotech/novo-nordisk-discards-kidney-disease-drug-13b-deal-wake-phase-3-fail https://www.fiercebiotech.com/biotech/novo-nordisk-discards-kidney-disease-drug-13b-deal-wake-phase-3-fail" [X Link](https://x.com/McFlusion/status/1854480966057709836) 2024-11-07T11:08Z [--] followers, [--] engagements "AbbVie Shares Plummet 12% as Cerevel Schizophrenia Asset Fails Phase II Trials https://www.biospace.com/drug-development/abbvie-shares-plummet-12-as-cerevel-schizophrenia-asset-fails-phase-ii-trials https://www.biospace.com/drug-development/abbvie-shares-plummet-12-as-cerevel-schizophrenia-asset-fails-phase-ii-trials" [X Link](https://x.com/McFlusion/status/1856008289890230440) 2024-11-11T16:17Z [--] followers, [--] engagements "Pfizer explores sale of hospital drugs unit amid activist investors call for accountability: Reuters https://www.fiercepharma.com/pharma/pfizer-explores-sale-hospital-drugs-unit-amid-activist-investors-call-accountability-reuters https://www.fiercepharma.com/pharma/pfizer-explores-sale-hospital-drugs-unit-amid-activist-investors-call-accountability-reuters" [X Link](https://x.com/McFlusion/status/1856393413685342672) 2024-11-12T17:47Z [--] followers, [--] engagements "RFK Jr vow to purge FDA sets up collision with Big Pharma https://www.reuters.com/business/healthcare-pharmaceuticals/rfk-jr-vow-purge-fda-sets-up-collision-with-big-pharma-2024-11-15/ https://www.reuters.com/business/healthcare-pharmaceuticals/rfk-jr-vow-purge-fda-sets-up-collision-with-big-pharma-2024-11-15/" [X Link](https://x.com/McFlusion/status/1857394618645581861) 2024-11-15T12:06Z [--] followers, [--] engagements "Hidden data on obesity prospect wipe $12B off Amgen market cap https://www.fiercebiotech.com/biotech/hidden-data-obesity-prospect-wipe-12b-amgen-market-cap https://www.fiercebiotech.com/biotech/hidden-data-obesity-prospect-wipe-12b-amgen-market-cap" [X Link](https://x.com/McFlusion/status/1857397597712887898) 2024-11-15T12:17Z [--] followers, [--] engagements "Top FDA vaccine official says RFK Jr. nomination is a chance for scientists to make the case for vaccines via @qz https://qz.com/fda-peter-marks-rjk-vaccines-1851705107utm_medium=sharefromsite&utm_source=quartz_twitter https://qz.com/fda-peter-marks-rjk-vaccines-1851705107utm_medium=sharefromsite&utm_source=quartz_twitter" [X Link](https://x.com/McFlusion/status/1859912541419520350) 2024-11-22T10:51Z [--] followers, [--] engagements "Alector's AbbVie-partnered Alzheimer's bid fails mid-stage study via @fwpharma https://firstwordpharma.com/story/5916442 https://firstwordpharma.com/story/5916442" [X Link](https://x.com/McFlusion/status/1861376412168446251) 2024-11-26T11:48Z [--] followers, [--] engagements "Look out Pfizer: BridgeBio scores 'best-case' FDA nod for Attruby in cardiomyopathy https://www.fiercepharma.com/pharma/comeback-story-bridgebio-scores-fda-nod-cardiomyopathy-set-take-pfizer https://www.fiercepharma.com/pharma/comeback-story-bridgebio-scores-fda-nod-cardiomyopathy-set-take-pfizer" [X Link](https://x.com/McFlusion/status/1861379972872405169) 2024-11-26T12:02Z [--] followers, [--] engagements "Takeda pays Keros $200M upfront for rival to BMS' booming blockbuster Reblozyl https://www.fiercebiotech.com/biotech/takeda-pays-keros-200m-upfront-rival-bms-booming-blockbuster-reblozyl https://www.fiercebiotech.com/biotech/takeda-pays-keros-200m-upfront-rival-bms-booming-blockbuster-reblozyl" [X Link](https://x.com/McFlusion/status/1863993018967032092) 2024-12-03T17:05Z [--] followers, [--] engagements "Reckitt shells out $200M to expand its Mucinex production site in North Carolina https://www.fiercepharma.com/manufacturing/reckitt-shells-out-200m-expand-footprint-its-nc-mucinex-production-site https://www.fiercepharma.com/manufacturing/reckitt-shells-out-200m-expand-footprint-its-nc-mucinex-production-site" [X Link](https://x.com/McFlusion/status/1863993235175006706) 2024-12-03T17:06Z [--] followers, [--] engagements "Amylin Commands Weight Loss Attention as Industry Anticipates Novos Phase III CagriSema Readout https://www.biospace.com/drug-development/amylin-commands-weight-loss-attention-as-industry-anticipates-novos-phase-iii-cagrisema-readout https://www.biospace.com/drug-development/amylin-commands-weight-loss-attention-as-industry-anticipates-novos-phase-iii-cagrisema-readout" [X Link](https://x.com/McFlusion/status/1864637467829162187) 2024-12-05T11:46Z [--] followers, [---] engagements "Syringe Recall: Cardinal Health Removes Certain Monoject U-100 mL Insulin Syringe Luer Lock with Tip Cap Soft Packs due to Incompatibility with Needleless Connectors https://www.fda.gov/medical-devices/medical-device-recalls/syringe-recall-cardinal-health-removes-certain-monoject-u-100-ml-insulin-syringe-luer-lock-tip-cap https://www.fda.gov/medical-devices/medical-device-recalls/syringe-recall-cardinal-health-removes-certain-monoject-u-100-ml-insulin-syringe-luer-lock-tip-cap" [X Link](https://x.com/McFlusion/status/1864996150677316054) 2024-12-06T11:31Z [--] followers, [--] engagements "A Month After Stunning Schizophrenia Fail AbbVies Other Cerevel Asset Shines Again https://www.biospace.com/drug-development/a-month-after-stunning-schizophrenia-fail-abbvies-other-cerevel-asset-shines-again https://www.biospace.com/drug-development/a-month-after-stunning-schizophrenia-fail-abbvies-other-cerevel-asset-shines-again" [X Link](https://x.com/McFlusion/status/1866165498938814946) 2024-12-09T16:58Z [--] followers, [--] engagements "Early Alert: Infusion Pump Issue from Fresenius Kabi USA https://www.fda.gov/medical-devices/medical-device-recalls/early-alert-infusion-pump-issue-fresenius-kabi-usa https://www.fda.gov/medical-devices/medical-device-recalls/early-alert-infusion-pump-issue-fresenius-kabi-usa" [X Link](https://x.com/McFlusion/status/1867162287766671523) 2024-12-12T10:59Z [--] followers, [--] engagements "AbbVie to acquire Roche spinout Nimble in immune drug deal via @BioPharmaDive https://www.biopharmadive.com/news/abbvie-nimble-acquire-deal-immune-drug-il-23/735498/ https://www.biopharmadive.com/news/abbvie-nimble-acquire-deal-immune-drug-il-23/735498/" [X Link](https://x.com/McFlusion/status/1867631154616221745) 2024-12-13T18:02Z [--] followers, [--] engagements "Novo Continues Manufacturing Spending Spree With $400M Denmark Expansion $200M Plant Purchase https://www.biospace.com/business/novo-continues-manufacturing-spending-spree-with-400m-denmark-expansion-200m-plant-purchase https://www.biospace.com/business/novo-continues-manufacturing-spending-spree-with-400m-denmark-expansion-200m-plant-purchase" [X Link](https://x.com/McFlusion/status/1868622012048130505) 2024-12-16T11:39Z [--] followers, [--] engagements "Fate of AstraZenecas Andexxa unclear as FDA rejects full approval via @fwpharma https://firstwordpharma.com/story/5921956 https://firstwordpharma.com/story/5921956" [X Link](https://x.com/McFlusion/status/1868979879217446993) 2024-12-17T11:21Z [--] followers, [---] engagements "Neuralink competitor Precision Neuroscience scores $102M to advance AI-powered brain implant via @fwhealthtech https://firstwordhealthtech.com/story/5921882 https://firstwordhealthtech.com/story/5921882" [X Link](https://x.com/McFlusion/status/1868986343541596629) 2024-12-17T11:47Z [--] followers, [--] engagements "Merck & Co. taps Chinese biotech for entry into oral GLP-1 arena via @fwpharma https://firstwordpharma.com/story/5922345 https://firstwordpharma.com/story/5922345" [X Link](https://x.com/McFlusion/status/1869491456723030328) 2024-12-18T21:14Z [--] followers, [--] engagements "Novo Nordisk's next-gen obesity drug CagriSema achieves lower weight loss than expected https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-next-gen-obesity-drug-cagrisema-achieves-lower-weight-loss-than-2024-12-20/ https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-next-gen-obesity-drug-cagrisema-achieves-lower-weight-loss-than-2024-12-20/" [X Link](https://x.com/McFlusion/status/1870063156174958623) 2024-12-20T11:06Z [--] followers, [---] engagements "Smart ring maker URA secures $200M to fuel AI developments via @fwhealthtech https://firstwordhealthtech.com/story/5922966 https://firstwordhealthtech.com/story/5922966" [X Link](https://x.com/McFlusion/status/1870064350217621778) 2024-12-20T11:10Z [--] followers, [--] engagements "Mirroring Merck's problem GSK's Jemperli-Zejula study in ovarian cancer misses survival goal https://www.fiercepharma.com/pharma/mirroring-mercks-problem-gsks-jermperli-zejula-test-ovarian-cancer-misses-survival-goal https://www.fiercepharma.com/pharma/mirroring-mercks-problem-gsks-jermperli-zejula-test-ovarian-cancer-misses-survival-goal" [X Link](https://x.com/McFlusion/status/1870151639304163636) 2024-12-20T16:57Z [--] followers, [--] engagements "Astellas Pharma US Inc. Issues Voluntary Nationwide Recall of One Lot of PROGRAF 0.5mg (Tacrolimus) and One Lot of ASTAGRAF XL 0.5mg (Tacrolimus Extended-Release Capsules) Because Bottles Shipped to U.S. May Contain Empty Capsules https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/astellas-pharma-us-inc-issues-voluntary-nationwide-recall-one-lot-prografr-05mg-tacrolimus-and-one https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/astellas-pharma-us-inc-issues-voluntary-nationwide-recall-one-lot-prografr-05mg-tacrolimus-and-one" [X Link](https://x.com/McFlusion/status/1871903878041710714) 2024-12-25T13:00Z [--] followers, [--] engagements "Calico draws blank in study of AbbVie-partnered drug for ALS via @fwpharma https://firstwordpharma.com/story/5925444 https://firstwordpharma.com/story/5925444" [X Link](https://x.com/McFlusion/status/1876600955359371522) 2025-01-07T12:05Z [--] followers, [--] engagements "FDA liver injury warning label for Agios' Pyrukynd The Pharmaletter https://www.thepharmaletter.com/fda-liver-injury-warning-label-for-agios-pyrukynd https://www.thepharmaletter.com/fda-liver-injury-warning-label-for-agios-pyrukynd" [X Link](https://x.com/McFlusion/status/1876938507429527819) 2025-01-08T10:26Z [--] followers, [--] engagements "Computing powerhouse AMD ventures into pharma via Absci partnership via @fwhealthtech https://firstwordhealthtech.com/story/5926220 https://firstwordhealthtech.com/story/5926220" [X Link](https://x.com/McFlusion/status/1877318358531445013) 2025-01-09T11:35Z [--] followers, [--] engagements "Humacyte gets FDA approval for bioengineered blood vessel https://www.ncbiotech.org/news/humacyte-gets-fda-approval-bioengineered-blood-vessel https://www.ncbiotech.org/news/humacyte-gets-fda-approval-bioengineered-blood-vessel" [X Link](https://x.com/McFlusion/status/1877380352773177450) 2025-01-09T15:42Z [--] followers, [--] engagements "New biotech Light Horse snags $1B+ Novartis pact on launch day via @fwpharma https://firstwordpharma.com/story/5926328 https://firstwordpharma.com/story/5926328" [X Link](https://x.com/McFlusion/status/1877679319939494165) 2025-01-10T11:30Z [--] followers, [--] engagements "HEALEY ALS Trial Serves Up More Disappointment as Denali AbbVie/Calico Fail https://www.biospace.com/drug-development/healey-als-trial-serves-up-more-disappointment-as-denali-abbvie-calico-fail https://www.biospace.com/drug-development/healey-als-trial-serves-up-more-disappointment-as-denali-abbvie-calico-fail" [X Link](https://x.com/McFlusion/status/1877746558994698603) 2025-01-10T15:57Z [--] followers, [--] engagements "Johnson & Johnson Makes Major Neuro Play With $14.6B Intra-Cellular Buyout https://www.biospace.com/business/johnson-johnson-makes-major-neuro-play-with-14-6b-intra-cellular-buyout https://www.biospace.com/business/johnson-johnson-makes-major-neuro-play-with-14-6b-intra-cellular-buyout" [X Link](https://x.com/McFlusion/status/1878845220550484475) 2025-01-13T16:43Z [--] followers, [--] engagements "Gilead Sciences US government settle patent case over HIV prevention drugs - https://www.reuters.com/legal/gilead-sciences-us-government-settle-patent-case-over-hiv-prevention-drugs-2025-01-15/ https://www.reuters.com/legal/gilead-sciences-us-government-settle-patent-case-over-hiv-prevention-drugs-2025-01-15/" [X Link](https://x.com/McFlusion/status/1879875617350643894) 2025-01-16T12:57Z [--] followers, [--] engagements "After delay FDA approves Amgen's Lumakras Vectibix combo for second-line CRC via @fwpharma https://firstwordpharma.com/story/5928703 https://firstwordpharma.com/story/5928703" [X Link](https://x.com/McFlusion/status/1880219188431843481) 2025-01-17T11:42Z [--] followers, [--] engagements "Ozempic Ibrance among next drugs picked by Medicare for price talks via @BioPharmaDive https://www.biopharmadive.com/news/medicare-drug-price-negotiations-second-round-semaglutide/736999/ https://www.biopharmadive.com/news/medicare-drug-price-negotiations-second-round-semaglutide/736999/" [X Link](https://x.com/McFlusion/status/1880243439192990202) 2025-01-17T13:19Z [--] followers, [--] engagements "Novo Nordisk Links High-Dose Wegovy to Increased Weight Loss in Phase III Trial https://www.biospace.com/drug-development/novo-nordisk-links-high-dose-wegovy-to-increased-weight-loss-in-phase-iii-trial https://www.biospace.com/drug-development/novo-nordisk-links-high-dose-wegovy-to-increased-weight-loss-in-phase-iii-trial" [X Link](https://x.com/McFlusion/status/1880289078048092563) 2025-01-17T16:20Z [--] followers, [--] engagements "McFlusion will exhibit on the [----] ISPE Facilities of the Future Conference in San Francisco on January 27-28 [----]. Connect with us at booth #408 in the Exhibit Hall. Click here to visit our online showroom: https://ispefof25.mapyourshow.com/8_0/exhibitor/exhibitor-details.cfmexhid=363602 https://ispefof25.mapyourshow.com/8_0/exhibitor/exhibitor-details.cfmexhid=363602" [X Link](https://x.com/McFlusion/status/1881358877104681422) 2025-01-20T15:11Z [--] followers, [--] engagements "FDA approves Johnson & Johnson nasal spray Spravato for depression https://www.cnbc.com/2025/01/21/fda-approves-johnson-johnson-nasal-spray-spravato-for-depression.html https://www.cnbc.com/2025/01/21/fda-approves-johnson-johnson-nasal-spray-spravato-for-depression.html" [X Link](https://x.com/McFlusion/status/1882033707646591405) 2025-01-22T11:52Z [--] followers, [--] engagements "J&J Says Deals Likely to Shrink After $14.6B Intra-Cellular Buy https://www.biospace.com/business/j-j-says-deals-likely-to-shrink-after-14-6b-intra-cellular-buy https://www.biospace.com/business/j-j-says-deals-likely-to-shrink-after-14-6b-intra-cellular-buy" [X Link](https://x.com/McFlusion/status/1882102876555895129) 2025-01-22T16:27Z [--] followers, [--] engagements "AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B https://www.biospace.com/business/abbvie-teams-up-with-neomorph-for-molecular-glue-collab-worth-up-to-1-64b https://www.biospace.com/business/abbvie-teams-up-with-neomorph-for-molecular-glue-collab-worth-up-to-1-64b" [X Link](https://x.com/McFlusion/status/1882467572534415844) 2025-01-23T16:36Z [--] followers, [--] engagements "AstraZeneca adds [---] jobs with $570M Canada investment https://www.fiercebiotech.com/biotech/astrazeneca-invests-570m-canada-expansion-adding-700-jobs https://www.fiercebiotech.com/biotech/astrazeneca-invests-570m-canada-expansion-adding-700-jobs" [X Link](https://x.com/McFlusion/status/1882760002068214193) 2025-01-24T11:58Z [--] followers, [--] engagements "Amgen settles Prolia patent suit with Celltrion teeing up potential biosimilar launch in June https://www.fiercepharma.com/pharma/after-sandoz-amgen-settles-patent-suit-celltrion-postponing-potential-launch-prolia-xgeva https://www.fiercepharma.com/pharma/after-sandoz-amgen-settles-patent-suit-celltrion-postponing-potential-launch-prolia-xgeva" [X Link](https://x.com/McFlusion/status/1884596169676103874) 2025-01-29T13:35Z [--] followers, [--] engagements "Merck & Co. says Winrevair too effective to withhold ends HYPERION study early via @fwpharma https://firstwordpharma.com/story/5931467 https://firstwordpharma.com/story/5931467" [X Link](https://x.com/McFlusion/status/1885289511162184087) 2025-01-31T11:30Z [--] followers, [--] engagements "AbbVie projects over $31B in Skyrizi Rinvoq sales by [----] via @fwpharma https://firstwordpharma.com/story/5931834 https://firstwordpharma.com/story/5931834" [X Link](https://x.com/McFlusion/status/1885338927613014254) 2025-01-31T14:46Z [--] followers, [--] engagements "Celltrion secures FDA approval for Actemra biosimilar https://www.koreabiomed.com/news/articleView.htmlidxno=26456 https://www.koreabiomed.com/news/articleView.htmlidxno=26456" [X Link](https://x.com/McFlusion/status/1886384604535267499) 2025-02-03T12:01Z [--] followers, [--] engagements "Merck & Co.'s pause on Gardasil shipments to China drags down outlook and shares via @fwpharma https://firstwordpharma.com/story/5932524 https://firstwordpharma.com/story/5932524" [X Link](https://x.com/McFlusion/status/1886792896919056555) 2025-02-04T15:04Z [--] followers, [--] engagements "Mercks Gardasil Woes Grow as China Trade War Heats Up https://www.biospace.com/business/mercks-gardasil-woes-grow-as-china-trade-war-heats-up https://www.biospace.com/business/mercks-gardasil-woes-grow-as-china-trade-war-heats-up" [X Link](https://x.com/McFlusion/status/1886822462777610332) 2025-02-04T17:01Z [--] followers, [--] engagements "Novo Partner Omega Waves Bankruptcy Flag from Sinking Ship https://www.biospace.com/business/novo-partner-omega-waves-bankruptcy-flag-from-sinking-ship https://www.biospace.com/business/novo-partner-omega-waves-bankruptcy-flag-from-sinking-ship" [X Link](https://x.com/McFlusion/status/1887083066247504302) 2025-02-05T10:17Z [--] followers, [--] engagements "Pfizer AbbVie's antibiotic FDA-approved for complicated intra-abdominal infections via @fwpharma https://firstwordpharma.com/story/5933743 https://firstwordpharma.com/story/5933743" [X Link](https://x.com/McFlusion/status/1888918025572614367) 2025-02-10T11:48Z [--] followers, [--] engagements "Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn https://pharmaphorum.com/news/bain-buys-japanese-pharma-mitsubishi-tanabe-34bn https://pharmaphorum.com/news/bain-buys-japanese-pharma-mitsubishi-tanabe-34bn" [X Link](https://x.com/McFlusion/status/1888925274827293136) 2025-02-10T12:17Z [--] followers, [--] engagements "Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout https://www.biospace.com/business/merck-kgaa-courts-cancer-biotech-springworks-for-potential-buyout https://www.biospace.com/business/merck-kgaa-courts-cancer-biotech-springworks-for-potential-buyout" [X Link](https://x.com/McFlusion/status/1889645137908666497) 2025-02-12T11:58Z [--] followers, [--] engagements "AbbVie joins obesity quest with $2.3B Gubra deal via @fwpharma https://firstwordpharma.com/story/5939139 https://firstwordpharma.com/story/5939139" [X Link](https://x.com/McFlusion/status/1896529874313175280) 2025-03-03T11:55Z [--] followers, [--] engagements "Biohaven skids after BHV-7000 bipolar study failure via @fwpharma https://firstwordpharma.com/story/5939341 https://firstwordpharma.com/story/5939341" [X Link](https://x.com/McFlusion/status/1896878954235228205) 2025-03-04T11:02Z [--] followers, [--] engagements "Novo Launches DTC Program for Wegovy Cutting Price to $499 a Month https://www.biospace.com/business/novo-launches-dtc-program-for-wegovy-cutting-price-to-499-a-month https://www.biospace.com/business/novo-launches-dtc-program-for-wegovy-cutting-price-to-499-a-month" [X Link](https://x.com/McFlusion/status/1897604742982828517) 2025-03-06T11:06Z [--] followers, [--] engagements "Texas court decision prevents compounders from producing knockoffs of Eli Lilly's tirzepatide https://www.fiercepharma.com/pharma/texas-court-decision-prevents-compounders-producing-knockoffs-eli-lilly-tirzepatide-drugs https://www.fiercepharma.com/pharma/texas-court-decision-prevents-compounders-producing-knockoffs-eli-lilly-tirzepatide-drugs" [X Link](https://x.com/McFlusion/status/1898062028008497163) 2025-03-07T17:23Z [--] followers, [--] engagements "FDA reviewers inspectors and investigators excluded from $25K buyout offer https://www.raps.org/News-and-Articles/News-Articles/2025/3/FDA-reviewers-inspectors-and-investigators-exclu https://www.raps.org/News-and-Articles/News-Articles/2025/3/FDA-reviewers-inspectors-and-investigators-exclu" [X Link](https://x.com/McFlusion/status/1899441791948202003) 2025-03-11T12:46Z [--] followers, [--] engagements "Merck & Co. bolsters US manufacturing base with new $1B vaccine plant via @fwpharma https://firstwordpharma.com/story/5941303nle=40680&nlc=105&from=article&nlp=top-stories_position-1 https://firstwordpharma.com/story/5941303nle=40680&nlc=105&from=article&nlp=top-stories_position-1" [X Link](https://x.com/McFlusion/status/1899782466573107533) 2025-03-12T11:20Z [--] followers, [--] engagements "Merck & Co. moves closer to FDA filing for HIV therapy that maintains viral suppression via @fwpharma" [X Link](https://x.com/McFlusion/status/1900139259664679061) 2025-03-13T10:57Z [--] followers, [--] engagements "Amid Trump's push to abolish DEI Roche and Novartis adjust hiring initiatives: reports https://www.fiercepharma.com/pharma/amid-trumps-push-abolish-dei-roche-novartis-adjust-diversity-plans https://www.fiercepharma.com/pharma/amid-trumps-push-abolish-dei-roche-novartis-adjust-diversity-plans" [X Link](https://x.com/McFlusion/status/1902759372985414100) 2025-03-20T16:29Z [--] followers, [--] engagements "'Not a cost-cutting exercise': Novo Nordisk CSO explains rationale behind pharma's R&D shake-up https://www.fiercebiotech.com/biotech/not-cost-cutting-exercise-novo-nordisk-reshapes-rd-setup https://www.fiercebiotech.com/biotech/not-cost-cutting-exercise-novo-nordisk-reshapes-rd-setup" [X Link](https://x.com/McFlusion/status/1903032202507506172) 2025-03-21T10:33Z [--] followers, [--] engagements "Novartis snags FDA nod for Fabhalta in another kidney disease but leaves room for rival Apellis https://www.fiercepharma.com/pharma/novartis-snags-fda-nod-fabhalta-another-kidney-disease-leaves-room-rival-apellis https://www.fiercepharma.com/pharma/novartis-snags-fda-nod-fabhalta-another-kidney-disease-leaves-room-rival-apellis" [X Link](https://x.com/McFlusion/status/1903148202699919609) 2025-03-21T18:14Z [--] followers, [--] engagements "Novartis Intrathecal Zolgensma Effective in Older Children https://www.biospace.com/drug-development/Novartis-intrathecal-zolgensma-effective-in-older-children https://www.biospace.com/drug-development/Novartis-intrathecal-zolgensma-effective-in-older-children" [X Link](https://x.com/McFlusion/status/1904113505466204671) 2025-03-24T10:10Z [--] followers, [--] engagements "AbbVie Lawsuit Alleges That Partner Genmab "Misappropriated Trade Secrets https://www.biospace.com/business/abbvie-lawsuit-alleges-that-partner-genmab-misappropriated-trade-secrets https://www.biospace.com/business/abbvie-lawsuit-alleges-that-partner-genmab-misappropriated-trade-secrets" [X Link](https://x.com/McFlusion/status/1904192799848690114) 2025-03-24T15:25Z [--] followers, [--] engagements "FDA Action Alert: Amgen Aldeyra and Argenx https://www.biospace.com/fda/fda-action-alert-amgen-aldeyra-and-argenx https://www.biospace.com/fda/fda-action-alert-amgen-aldeyra-and-argenx" [X Link](https://x.com/McFlusion/status/1906662333432094766) 2025-03-31T10:58Z [--] followers, [--] engagements "ACC25: Merck & Co.'s Winrevair reduces mortality in most severe PAH patients via @fwpharma https://firstwordpharma.com/story/5946052 https://firstwordpharma.com/story/5946052" [X Link](https://x.com/McFlusion/status/1907005242941579338) 2025-04-01T09:40Z [--] followers, [--] engagements "Pfizer's sixth Flagship deal will use AI to discover autoimmune disease candidates via @fwhealthtech https://firstwordhealthtech.com/story/5946592 https://firstwordhealthtech.com/story/5946592" [X Link](https://x.com/McFlusion/status/1907374452989395113) 2025-04-02T10:08Z [--] followers, [--] engagements "Gubra posts early data on AbbVie-partnered obesity asset via @fwpharma https://firstwordpharma.com/story/5946649 https://firstwordpharma.com/story/5946649" [X Link](https://x.com/McFlusion/status/1907374627594092738) 2025-04-02T10:08Z [--] followers, [--] engagements "Eli Lilly helps struggling Sangamo with $1.4B gene therapy deal https://www.fiercebiotech.com/biotech/eli-lilly-saves-sangamo-hitting-end-cash-runway-18m-upfront-deal https://www.fiercebiotech.com/biotech/eli-lilly-saves-sangamo-hitting-end-cash-runway-18m-upfront-deal" [X Link](https://x.com/McFlusion/status/1908097361106075693) 2025-04-04T10:00Z [--] followers, [--] engagements "BeiGene abandons ociperlimab over poor phase [--] prospects in latest blow to TIGITs https://www.fiercebiotech.com/biotech/beigene-abandons-ociperlimab-over-poor-phase-3-prospects-latest-blow-tigits https://www.fiercebiotech.com/biotech/beigene-abandons-ociperlimab-over-poor-phase-3-prospects-latest-blow-tigits" [X Link](https://x.com/McFlusion/status/1908097675112661061) 2025-04-04T10:01Z [--] followers, [--] engagements "Sareptas Duchenne Gene Therapy Placed on Hold in Europe Pending Death Investigation https://www.biospace.com/drug-development/sareptas-duchenne-gene-therapy-placed-on-hold-in-europe-pending-death-investigation https://www.biospace.com/drug-development/sareptas-duchenne-gene-therapy-placed-on-hold-in-europe-pending-death-investigation" [X Link](https://x.com/McFlusion/status/1908099124496380322) 2025-04-04T10:07Z [--] followers, [--] engagements "Eli Lilly CEO on Trump's tariffs: 'It'll be hard to come back from here' https://www.fiercepharma.com/pharma/lilly-ceo-ricks-trumps-tariffs-itll-be-hard-come-back-here https://www.fiercepharma.com/pharma/lilly-ceo-ricks-trumps-tariffs-itll-be-hard-come-back-here" [X Link](https://x.com/McFlusion/status/1908202914570465605) 2025-04-04T17:00Z [--] followers, [--] engagements "Novo Nordisk plugs more than $1B into upgrade of Brazilian manufacturing operations for injectable drugs including GLP-1s https://www.fiercepharma.com/manufacturing/novo-nordisk-plugs-more-1b-upgrade-brazilian-manufacturing-operations-injectable https://www.fiercepharma.com/manufacturing/novo-nordisk-plugs-more-1b-upgrade-brazilian-manufacturing-operations-injectable" [X Link](https://x.com/McFlusion/status/1909662139348050125) 2025-04-08T17:38Z [--] followers, [--] engagements "Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs via @investopedia https://www.investopedia.com/novartis-plans-usd23b-investment-in-us-facilities-as-trump-threatens-pharma-tariffs-11713217utm_source=social2&utm_medium=social&utm_campaign=shareurlbuttons https://www.investopedia.com/novartis-plans-usd23b-investment-in-us-facilities-as-trump-threatens-pharma-tariffs-11713217utm_source=social2&utm_medium=social&utm_campaign=shareurlbuttons" [X Link](https://x.com/McFlusion/status/1912092126436872544) 2025-04-15T10:34Z [--] followers, [--] engagements "White House launches national security investigation into pharma semiconductors https://thehill.com/policy/healthcare/5248629-white-house-pharma-semiconductor-tariffs/ https://thehill.com/policy/healthcare/5248629-white-house-pharma-semiconductor-tariffs/" [X Link](https://x.com/McFlusion/status/1912092553144414637) 2025-04-15T10:36Z [--] followers, [--] engagements "FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain FDA https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain" [X Link](https://x.com/McFlusion/status/1912093908781191538) 2025-04-15T10:41Z [--] followers, [--] engagements "Merck inks $493M biobucks deal to use Cyprumed's tech to create oral peptides https://www.fiercebiotech.com/biotech/merck-looks-leverage-cyprumeds-oral-drug-delivery-platform-its-peptides-493m-deal https://www.fiercebiotech.com/biotech/merck-looks-leverage-cyprumeds-oral-drug-delivery-platform-its-peptides-493m-deal" [X Link](https://x.com/McFlusion/status/1912440393645301855) 2025-04-16T09:38Z [--] followers, [--] engagements "Novartis pulls plug on Phase II knee osteoarthritis treatment via @fwpharma https://firstwordpharma.com/story/5950339 https://firstwordpharma.com/story/5950339" [X Link](https://x.com/McFlusion/status/1912814697692151809) 2025-04-17T10:25Z [--] followers, [--] engagements "Lilly's oral GLP-1 succeeds in first Phase III test via @fwpharma https://firstwordpharma.com/story/5950404 https://firstwordpharma.com/story/5950404" [X Link](https://x.com/McFlusion/status/1912859361484890118) 2025-04-17T13:23Z [--] followers, [--] engagements "EU authorizes Eisai-Biogen's drug for early Alzheimer's treatment - https://www.reuters.com/business/healthcare-pharmaceuticals/eu-authorizes-eisai-biogens-drug-treatment-early-alzheimers-disease-2025-04-15/ https://www.reuters.com/business/healthcare-pharmaceuticals/eu-authorizes-eisai-biogens-drug-treatment-early-alzheimers-disease-2025-04-15/" [X Link](https://x.com/McFlusion/status/1913180002528411816) 2025-04-18T10:37Z [--] followers, [--] engagements "Eli Lilly is overtaking Novo Nordisk in the diabetes obesity market: BMO analysts https://www.fiercepharma.com/pharma/eli-lilly-overtaking-novo-nordisk-diabetesobesity-market-analysts https://www.fiercepharma.com/pharma/eli-lilly-overtaking-novo-nordisk-diabetesobesity-market-analysts" [X Link](https://x.com/McFlusion/status/1913264567221711189) 2025-04-18T16:13Z [--] followers, [--] engagements "Amid industry's onshoring push Regeneron taps Fujifilm Diosynth for $3B 10-year commercial manufacturing team-up https://www.fiercepharma.com/manufacturing/amid-industry-onshoring-push-regeneron-taps-fujifilm-diosynth-3b-10-year-commercial https://www.fiercepharma.com/manufacturing/amid-industry-onshoring-push-regeneron-taps-fujifilm-diosynth-3b-10-year-commercial" [X Link](https://x.com/McFlusion/status/1914712030134551022) 2025-04-22T16:04Z [--] followers, [--] engagements "Boehringer to expand oncology presence with $572m Tessellate Bio deal via @PharmaTechFocus https://www.pharmaceutical-technology.com/news/boehringer-to-expand-oncology-presence-with-572m-tessellate-bio-deal/ https://www.pharmaceutical-technology.com/news/boehringer-to-expand-oncology-presence-with-572m-tessellate-bio-deal/" [X Link](https://x.com/McFlusion/status/1915355875130139074) 2025-04-24T10:43Z [--] followers, [--] engagements "Merck & Co.'s injectable Keytruda triggers patent lawsuit from Halozyme via @fwpharma https://firstwordpharma.com/story/5952473 https://firstwordpharma.com/story/5952473" [X Link](https://x.com/McFlusion/status/1915715805892743475) 2025-04-25T10:33Z [--] followers, [--] engagements "Merck & Co. maintains full-year projections while warning of tariff hit via @fwpharma https://firstwordpharma.com/story/5952668 https://firstwordpharma.com/story/5952668" [X Link](https://x.com/McFlusion/status/1915715948251697543) 2025-04-25T10:34Z [--] followers, [--] engagements "Thermo Fisher To Invest Addl. $2 Bln In U.S. To Boost Manufacturing Nasdaq https://www.rttnews.com/3531422/thermo-fisher-to-invest-addl-2-bln-in-u-s-to-boost-manufacturing.aspx https://www.rttnews.com/3531422/thermo-fisher-to-invest-addl-2-bln-in-u-s-to-boost-manufacturing.aspx" [X Link](https://x.com/McFlusion/status/1915716734696247409) 2025-04-25T10:37Z [--] followers, [--] engagements "PCI Pharma Services to Acquire Ajinomoto Althea https://www.contractpharma.com/breaking-news/pci-pharma-services-to-acquire-ajinomoto-althea/ https://www.contractpharma.com/breaking-news/pci-pharma-services-to-acquire-ajinomoto-althea/" [X Link](https://x.com/McFlusion/status/1915717906584818168) 2025-04-25T10:41Z [--] followers, [--] engagements "Summit Akesos Keytruda Challenger Wins Chinese OK as US Approval Questions Linger https://www.biospace.com/drug-development/summit-akesos-keytruda-challenger-wins-chinese-ok-as-us-approval-questions-linger https://www.biospace.com/drug-development/summit-akesos-keytruda-challenger-wins-chinese-ok-as-us-approval-questions-linger" [X Link](https://x.com/McFlusion/status/1916966714220163350) 2025-04-28T21:24Z [--] followers, [--] engagements "Dutch biotech emerges with $50M plug-and-play antibody engineering platform via @fwpharma https://firstwordpharma.com/story/5952551 https://firstwordpharma.com/story/5952551" [X Link](https://x.com/McFlusion/status/1917099176795525137) 2025-04-29T06:10Z [--] followers, [--] engagements "Novo moves past GLP-1 spat with Hims & Hers tapping telehealth company to offer discounted Wegovy https://www.fiercepharma.com/pharma/novo-moves-past-glp-1-spat-hims-tapping-telehealth-companies-offer-low-cost-wegovy https://www.fiercepharma.com/pharma/novo-moves-past-glp-1-spat-hims-tapping-telehealth-companies-offer-low-cost-wegovy" [X Link](https://x.com/McFlusion/status/1917259590682476551) 2025-04-29T16:48Z [--] followers, [--] engagements "Samsung Biologics inks $518M production contract with US pharma extending CDMO's dealmaking streak https://www.fiercepharma.com/manufacturing/samsung-biologics-production-streak-continues-518m-us-pharma-contract https://www.fiercepharma.com/manufacturing/samsung-biologics-production-streak-continues-518m-us-pharma-contract" [X Link](https://x.com/McFlusion/status/1918185163911209025) 2025-05-02T06:05Z [--] followers, [--] engagements "RFK Jr. to require placebo-controlled studies for new vaccines : Shots - Health News : NPR https://www.npr.org/sections/shots-health-news/2025/05/01/nx-s1-5383172/rfk-jr-placebo-vaccine-testing-studies https://www.npr.org/sections/shots-health-news/2025/05/01/nx-s1-5383172/rfk-jr-placebo-vaccine-testing-studies" [X Link](https://x.com/McFlusion/status/1918185471651303561) 2025-05-02T06:07Z [--] followers, [--] engagements "In major blow for Lilly Novo strikes deal giving Wegovy preferred access on CVS Caremark formulary https://www.fiercepharma.com/pharma/major-blow-lilly-novo-strikes-deal-giving-wegovy-preferred-access-cvs-caremark-formulary https://www.fiercepharma.com/pharma/major-blow-lilly-novo-strikes-deal-giving-wegovy-preferred-access-cvs-caremark-formulary" [X Link](https://x.com/McFlusion/status/1918377726945443994) 2025-05-02T18:51Z [--] followers, [--] engagements "Vertex discontinues AAV vector research for gene therapies https://www.fiercebiotech.com/biotech/vertex-discontinues-aav-vector-research-gene-therapies https://www.fiercebiotech.com/biotech/vertex-discontinues-aav-vector-research-gene-therapies" [X Link](https://x.com/McFlusion/status/1919335552739836223) 2025-05-05T10:17Z [--] followers, [--] engagements "BREAKING: White House Releases Budget Proposal Slashing HHS Agencies https://hcinnovationgroup.com/policy-value-based-care/article/55287780/breaking-white-house-releases-budget-proposal-slashing-hhs-agencies https://hcinnovationgroup.com/policy-value-based-care/article/55287780/breaking-white-house-releases-budget-proposal-slashing-hhs-agencies" [X Link](https://x.com/McFlusion/status/1919335933960130636) 2025-05-05T10:18Z [--] followers, [--] engagements "FDA accepts filing application for oral semaglutide [--] mg which if approved would be the first oral GLP-1 treatment for obesity https://www.prnewswire.com/news-releases/fda-accepts-filing-application-for-oral-semaglutide-25-mg-which-if-approved-would-be-the-first-oral-glp-1-treatment-for-obesity-302445232.html https://www.prnewswire.com/news-releases/fda-accepts-filing-application-for-oral-semaglutide-25-mg-which-if-approved-would-be-the-first-oral-glp-1-treatment-for-obesity-302445232.html" [X Link](https://x.com/McFlusion/status/1919336491139908087) 2025-05-05T10:20Z [--] followers, [--] engagements "PTC's Novartis-partnered Huntington's drug disappoints in mid-stage data reveal via @fwpharma https://firstwordpharma.com/story/5956490 https://firstwordpharma.com/story/5956490" [X Link](https://x.com/McFlusion/status/1919704935546966180) 2025-05-06T10:44Z [--] followers, [--] engagements "OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation WIRED https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/ https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/" [X Link](https://x.com/McFlusion/status/1920420537433518489) 2025-05-08T10:08Z [--] followers, [--] engagements "FDA eyes full AI integration by June as Makary touts genAI pilot success via @fwhealthtech https://firstwordhealthtech.com/story/5958730 https://firstwordhealthtech.com/story/5958730" [X Link](https://x.com/McFlusion/status/1920775709103907014) 2025-05-09T09:39Z [--] followers, [--] engagements "Citing tariffs Illumina slashes guidance confirms SEC's Grail investigation is closed via @fwhealthtech https://firstwordhealthtech.com/story/5959070 https://firstwordhealthtech.com/story/5959070" [X Link](https://x.com/McFlusion/status/1920779196223090689) 2025-05-09T09:53Z [--] followers, [--] engagements "Lilly touts more Zepbound data from head-to-head Wegovy trial via @fwpharma https://firstwordpharma.com/story/5959568 https://firstwordpharma.com/story/5959568" [X Link](https://x.com/McFlusion/status/1921874280255512719) 2025-05-12T10:25Z [--] followers, [--] engagements "AbbVie plant workers in Ireland threaten to strike over pay dispute: reports https://www.fiercepharma.com/manufacturing/abbvie-plant-workers-ireland-threaten-strike-over-pay-dispute https://www.fiercepharma.com/manufacturing/abbvie-plant-workers-ireland-threaten-strike-over-pay-dispute" [X Link](https://x.com/McFlusion/status/1922696519066563052) 2025-05-14T16:52Z [--] followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@McFlusion McFlusion
McFlusion posts on X about novartis, $abbv, sanofi, eli lilly the most. They currently have [-------] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.
Engagements: [-----] #
- [--] Week [---] +130%
- [--] Month [-----] +60%
- [--] Months [-----] +123%
- [--] Year [------] +320%
Mentions: [--] #
- [--] Week [--] +95%
- [--] Month [--] +75%
- [--] Months [---] +91%
- [--] Year [---] +287%
Followers: [-------] #
- [--] Week [--] no change
- [--] Month [--] no change
- [--] Months [--] +2.10%
- [--] Year [--] +33%
CreatorRank: undefined #
Social Influence
Social category influence stocks finance countries technology brands travel destinations us election currencies vc firms celebrities automotive brands
Social topic influence novartis, $abbv #85, sanofi, eli lilly, novo, investment, rfk, $1b, pharma, acquisition
Top accounts mentioned or mentioned by @fwpharma @fwhealthtech @statnews @biopharmadive @pharmatechfocus @lmtonline @qz @investopedia @yahoonews @pharmavoice @barronsonline @medtechdive @sfgate @drmakaryfda @seckennedy
Top assets mentioned Novartis AG (NVS) AbbVie Inc (ABBV) Sanofi (SNY) Eli Lilly and Company (LLY) Pfizer, Inc. (PFE) Merck & Co., Inc. (MRK) CVS Health Corp (CVS) GSK plc (GSK)
Top Social Posts
Top posts by engagements in the last [--] hours
"Astellas hit by US patent verdict for incontinence drug"
X Link 2023-06-13T11:20Z [--] followers, [--] engagements
"AbbVie Removes Two Early-Stage Cancer Assets from Pipeline BioSpace #jobs"
X Link 2023-08-28T10:51Z [--] followers, [--] engagements
"British drugmaker GSK Plc said on Friday the U.S. Food and Drug Administration had approved its experimental oral therapy to treat anemia in patients with a type of bone marrow cancer called myelofibrosis"
X Link 2023-09-18T09:13Z [--] followers, [--] engagements
"We will be exhibiting on the [----] ISPE Annual Meeting & Expo in Las Vegas on Oct. 16-18. Connect with us at booth #927 in the Shoreline Exhibit Hall. Click here to visit our online showroom:"
X Link 2023-10-10T14:03Z [--] followers, [--] engagements
"Illumina to Divest Cancer Test Maker Grail if It Loses US or EU Court Appeal"
X Link 2023-10-12T11:14Z [--] followers, [--] engagements
"Novo Nordisk to buy hypertension drug from KBP Biosciences for $1.3 billion via @fwpharma https://firstwordpharma.com/story/5789945 https://firstwordpharma.com/story/5789945"
X Link 2023-10-16T12:26Z [--] followers, [--] engagements
"Brand-new $112 million life sciences hub opens in The Woodlands via @lmtonline"
X Link 2023-10-20T14:16Z [--] followers, [--] engagements
"Fast-growing Samsung Biologics chided by FDA over shortfalls at plant in Korea"
X Link 2023-10-24T12:40Z [--] followers, [--] engagements
"Fresenius Medical Care Recalls Some Hemodialysis Machines for Potential Exposure to Toxic Compounds https://www.fda.gov/medical-devices/medical-device-recalls/fresenius-medical-care-recalls-some-hemodialysis-machines-potential-exposure-toxic-compounds https://www.fda.gov/medical-devices/medical-device-recalls/fresenius-medical-care-recalls-some-hemodialysis-machines-potential-exposure-toxic-compounds"
X Link 2023-10-25T11:15Z [--] followers, [--] engagements
"Amgen plans to lay off [---] former Horizon employees after $28B buyout"
X Link 2023-10-25T11:18Z [--] followers, [--] engagements
"Cipla Limited - [------] - 11/17/2023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023"
X Link 2023-11-22T13:41Z [--] followers, [--] engagements
"Veteran Big Pharma chief lashes out at Tucker Carlson Elon Musks drug ad criticism on X"
X Link 2023-12-05T11:30Z [--] followers, [--] engagements
"Cipla Limited - [------] - 11/17/2023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023"
X Link 2023-12-06T14:04Z [--] followers, [--] engagements
"Cipla Limited - [------] - 11/17/2023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023"
X Link 2023-12-13T13:22Z [--] followers, [--] engagements
"Olympus Corporation of the Americas Recalls Bronchofiberscopes and Bronchovideoscopes Because They Can Lead to Burns and Fire"
X Link 2023-12-20T11:23Z [--] followers, [--] engagements
"Philips North America LLC Recalls Panorama 1.0T HFO due to a Risk of Explosion During a Quench Procedure Caused by Excessive Pressure Buildup of Helium Gas"
X Link 2023-12-20T18:51Z [--] followers, [--] engagements
"Cipla Limited - [------] - 11/17/2023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023 https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cipla-limited-660904-11172023"
X Link 2023-12-20T18:52Z [--] followers, [--] engagements
"Novo Nordisk submits application for massive manufacturing campus near Dublin"
X Link 2024-01-02T07:15Z [--] followers, [--] engagements
"BMS enters radiopharma race with $4.1B acquisition of RayzeBio just [--] months after biotech went public"
X Link 2024-01-02T07:17Z [--] followers, [--] engagements
"An attractive opportunity for investing: Goldman Sachs closes $650M fund aimed at biotechs"
X Link 2024-01-04T07:21Z [--] followers, [--] engagements
"Merck & Co. looks to snare Harpoon with $700-million bid: report via @fwpharma"
X Link 2024-01-08T10:22Z [--] followers, [--] engagements
"AbbVie launches pump-based Parkinsons drug in EU"
X Link 2024-01-11T14:31Z [--] followers, [--] engagements
"Merck & Co. signs $220M macrocyclic peptide deal after hailing next wave of drug discovery https://www.fiercebiotech.com/biotech/merck-co-signs-220m-macrocyclic-peptide-deal-after-hailing-next-wave-drug-discovery https://www.fiercebiotech.com/biotech/merck-co-signs-220m-macrocyclic-peptide-deal-after-hailing-next-wave-drug-discovery"
X Link 2024-01-24T12:14Z [--] followers, [--] engagements
"Gilead Sciences raises stake in cancer-centric Arcus Biosciences to 33% https://www.channelnewsasia.com/business/gilead-sciences-raises-stake-cancer-centric-arcus-biosciences-33-4084126 https://www.channelnewsasia.com/business/gilead-sciences-raises-stake-cancer-centric-arcus-biosciences-33-4084126"
X Link 2024-01-30T13:42Z [--] followers, [--] engagements
"White House wins in first Medicare negotiation legal ruling"
X Link 2024-02-13T12:47Z [--] followers, [--] engagements
"As Catalent moves toward Novo buyout its restructuring claimed [---] jobs last year"
X Link 2024-02-15T17:32Z [--] followers, [--] engagements
"Novo Nordisk and Eli Lilly rival soars 35% after promising weight loss drug results"
X Link 2024-02-28T11:46Z [--] followers, [--] engagements
"Novo Nordisk's amycretin outshines Wegovy in early obesity study via @fwpharma"
X Link 2024-03-07T16:30Z [--] followers, [--] engagements
"After Kyowa Kirin buyout Orchard scores FDA approval for first MLD gene therapy in the US"
X Link 2024-03-19T08:27Z [--] followers, [--] engagements
"Sanders Blasts Novo Nordisk for Outrageous Price of Ozempic Wegovy BioSpace #jobs https://www.biospace.com/article/sanders-blasts-novo-nordisk-for-outrageous-price-of-ozempic-wegovy/utm_source=socialmedia https://www.biospace.com/article/sanders-blasts-novo-nordisk-for-outrageous-price-of-ozempic-wegovy/utm_source=socialmedia"
X Link 2024-03-28T16:00Z [--] followers, [--] engagements
"Novo Nordisk triumphs in UK probe of 'hyperbolic' Wegovy claims https://www.fiercepharma.com/marketing/novo-nordisk-triumphs-uk-probe-hyperbolic-wegovy-claims https://www.fiercepharma.com/marketing/novo-nordisk-triumphs-uk-probe-hyperbolic-wegovy-claims"
X Link 2024-04-03T16:39Z [--] followers, [--] engagements
"Aruba Aloe Balm N.V. Issues Voluntary Nationwide Recall of Aruba Aloe Hand Sanitizer Gel Alcohol 80% and Aruba Aloe Alcoholada Gel Due to Presence of Methanol https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aruba-aloe-balm-nv-issues-voluntary-nationwide-recall-aruba-aloe-hand-sanitizer-gel-alcohol-80-and https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/aruba-aloe-balm-nv-issues-voluntary-nationwide-recall-aruba-aloe-hand-sanitizer-gel-alcohol-80-and"
X Link 2024-04-09T12:02Z [--] followers, [--] engagements
"Eli Lilly to acquire manufacturing facility from Nexus Pharma https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-manufacturing-facility-nexus-pharma-2024-04-22/ https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-manufacturing-facility-nexus-pharma-2024-04-22/"
X Link 2024-04-23T12:10Z [--] followers, [--] engagements
"Supreme Court Denies Vandas Petition in Hetlioz Patent Case Against Teva BioSpace #jobs https://www.biospace.com/article/supreme-court-denies-vanda-s-petition-in-hetlioz-patent-case-against-teva-/utm_source=socialmedia https://www.biospace.com/article/supreme-court-denies-vanda-s-petition-in-hetlioz-patent-case-against-teva-/utm_source=socialmedia"
X Link 2024-04-23T12:12Z [--] followers, [--] engagements
"Sanofi pulls off phase [--] LUNA landing sparking race to regulators for BTK inhibitor https://www.fiercebiotech.com/biotech/sanofi-pulls-phase-3-luna-landing-sparking-race-regulators-btk-inhibitor https://www.fiercebiotech.com/biotech/sanofi-pulls-phase-3-luna-landing-sparking-race-regulators-btk-inhibitor"
X Link 2024-04-24T11:45Z [--] followers, [--] engagements
"Weight-loss drug drives Eli Lilly to raise [----] sales forecast by $2 billion https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-beats-profit-estimates-diabetes-weight-loss-drug-strength-2024-04-30/ https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-beats-profit-estimates-diabetes-weight-loss-drug-strength-2024-04-30/"
X Link 2024-05-01T10:37Z [--] followers, [--] engagements
"Tandem Diabetes Care Inc. Recalls Version [---] of the Apple iOS t:connect Mobile App Used in Conjunction with t:slim X2 Insulin Pump with Control-IQ Technology Prompted by a Software Problem Leading to Pump Battery Depletion https://www.fda.gov/medical-devices/medical-device-recalls/tandem-diabetes-care-inc-recalls-version-27-apple-ios-tconnect-mobile-app-used-conjunction-tslim-x2 https://www.fda.gov/medical-devices/medical-device-recalls/tandem-diabetes-care-inc-recalls-version-27-apple-ios-tconnect-mobile-app-used-conjunction-tslim-x2"
X Link 2024-05-09T12:17Z [--] followers, [--] engagements
"Johnson & Johnson looks to offload remaining Kenvue stake in $3.75B deal https://www.fiercepharma.com/pharma/johnson-johnson-looks-offload-remaining-kenvue-stake-375b-deal https://www.fiercepharma.com/pharma/johnson-johnson-looks-offload-remaining-kenvue-stake-375b-deal"
X Link 2024-05-13T17:47Z [--] followers, [--] engagements
"Philips Respironics Inc. Recalls Trilogy Evo Continuous Ventilators due to a Software-Related Possible Power Malfunction https://www.fda.gov/medical-devices/medical-device-recalls/philips-respironics-inc-recalls-trilogy-evo-continuous-ventilators-due-software-related-possible https://www.fda.gov/medical-devices/medical-device-recalls/philips-respironics-inc-recalls-trilogy-evo-continuous-ventilators-due-software-related-possible"
X Link 2024-05-13T17:47Z [--] followers, [--] engagements
"Sanders Warns Weight-Loss Drugs Could Bankrupt US Healthcare System BioSpace #jobs https://www.biospace.com/article/sanders-warns-weight-loss-drugs-could-bankrupt-us-healthcare-system/utm_source=socialmedia https://www.biospace.com/article/sanders-warns-weight-loss-drugs-could-bankrupt-us-healthcare-system/utm_source=socialmedia"
X Link 2024-05-16T15:52Z [--] followers, [--] engagements
"Hologic Inc. Recalls BioZorb Marker Due to Complications with Implanted Devices https://www.fda.gov/medical-devices/medical-device-recalls/hologic-inc-recalls-biozorb-marker-due-complications-implanted-devices https://www.fda.gov/medical-devices/medical-device-recalls/hologic-inc-recalls-biozorb-marker-due-complications-implanted-devices"
X Link 2024-05-23T11:01Z [--] followers, [--] engagements
"US FDA panel votes against Novo Nordisk's weekly insulin in type [--] diabetes patients https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-against-use-novo-nordisks-weekly-insulin-type-1-diabetes-2024-05-24/ https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-votes-against-use-novo-nordisks-weekly-insulin-type-1-diabetes-2024-05-24/"
X Link 2024-05-28T10:29Z [--] followers, [--] engagements
"Mexican man dies in first human case of H5N2 bird flu https://pharmaphorum.com/news/mexican-man-dies-first-human-case-h5n2-bird-flu https://pharmaphorum.com/news/mexican-man-dies-first-human-case-h5n2-bird-flu"
X Link 2024-06-06T12:04Z [--] followers, [--] engagements
"AbbVie's tight grip on Humira market raises concerns about biosimilars https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-tight-grip-humira-market-raises-concerns-about-biosimilars-2024-06-07/ https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-tight-grip-humira-market-raises-concerns-about-biosimilars-2024-06-07/"
X Link 2024-06-10T11:13Z [--] followers, [--] engagements
"Novo Nordisk CEO agrees to testify on semaglutide pricing https://pharmaphorum.com/news/novo-nordisk-ceo-agrees-testify-semaglutide-pricing https://pharmaphorum.com/news/novo-nordisk-ceo-agrees-testify-semaglutide-pricing"
X Link 2024-06-18T14:05Z [--] followers, [--] engagements
"FDA Action Alert: Merck Verona AbbVie and Rocket BioSpace #jobs https://www.biospace.com/article/fda-action-alert-merck-verona-abbvie-and-rocket/utm_source=socialmedia https://www.biospace.com/article/fda-action-alert-merck-verona-abbvie-and-rocket/utm_source=socialmedia"
X Link 2024-06-24T10:37Z [--] followers, [--] engagements
"Major plans for South Dublin pharma plant cancelled https://www.fm104.ie/news/fm104-news/major-plans-for-south-dublin-pharma-plant-cancelled/ https://www.fm104.ie/news/fm104-news/major-plans-for-south-dublin-pharma-plant-cancelled/"
X Link 2024-06-24T10:54Z [--] followers, [--] engagements
"Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing - https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-maker-novo-nordisk-spend-41-bln-boost-us-manufacturing-2024-06-24/ https://www.reuters.com/business/healthcare-pharmaceuticals/wegovy-maker-novo-nordisk-spend-41-bln-boost-us-manufacturing-2024-06-24/"
X Link 2024-06-25T08:39Z [--] followers, [--] engagements
"FDA Again Hits AbbVie Parkinsons Treatment With Complete Response Letter BioSpace #jobs https://www.biospace.com/article/fda-again-hits-abbvie-parkinson-s-treatment-with-crl-/utm_source=socialmedia https://www.biospace.com/article/fda-again-hits-abbvie-parkinson-s-treatment-with-crl-/utm_source=socialmedia"
X Link 2024-06-25T15:43Z [--] followers, [--] engagements
"FDA Again Hits AbbVie Parkinsons Treatment With Complete Response Letter BioSpace #jobs https://www.biospace.com/article/fda-again-hits-abbvie-parkinson-s-treatment-with-crl-/utm_source=socialmedia https://www.biospace.com/article/fda-again-hits-abbvie-parkinson-s-treatment-with-crl-/utm_source=socialmedia"
X Link 2024-06-26T10:58Z [--] followers, [--] engagements
"Supreme Court Rejects Purdues Opioid Pact With Sackler Shield https://www.bloomberg.com/news/articles/2024-06-27/supreme-court-rejects-purdue-s-opioid-pact-with-sackler-shield https://www.bloomberg.com/news/articles/2024-06-27/supreme-court-rejects-purdue-s-opioid-pact-with-sackler-shield"
X Link 2024-06-27T14:21Z [--] followers, [--] engagements
"AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave https://www.fiercebiotech.com/biotech/abbvie-sweeps-celsius-therapeutics-250m-summer-heat-wave https://www.fiercebiotech.com/biotech/abbvie-sweeps-celsius-therapeutics-250m-summer-heat-wave"
X Link 2024-06-28T13:10Z [--] followers, [--] engagements
"Merck's Capvaxive gears up to challenge Pfizer's dominant Prevnar with CDC panel backing https://www.fiercepharma.com/pharma/mercks-new-capvaxive-ready-challenge-pfizers-dominant-prevnar-cdc-panel-endorsement https://www.fiercepharma.com/pharma/mercks-new-capvaxive-ready-challenge-pfizers-dominant-prevnar-cdc-panel-endorsement"
X Link 2024-06-28T17:08Z [--] followers, [--] engagements
"Novo Nordisk Partners With BE&K For Facility Expansion In Clayton NC Contract Pharma https://www.contractpharma.com/contents/view_breaking-news/2024-06-28/novo-nordisk-partners-with-bek-for-facility-expansion-in-clayton-nc/ https://www.contractpharma.com/contents/view_breaking-news/2024-06-28/novo-nordisk-partners-with-bek-for-facility-expansion-in-clayton-nc/"
X Link 2024-07-08T10:27Z [--] followers, [--] engagements
"Generic-Viagra Safety Called Into Doubt After False Data Found by FDA https://www.bloomberg.com/news/articles/2024-07-09/generic-viagra-cialis-lipitor-safety-in-question-after-fda-finds-false-data https://www.bloomberg.com/news/articles/2024-07-09/generic-viagra-cialis-lipitor-safety-in-question-after-fda-finds-false-data"
X Link 2024-07-09T10:36Z [--] followers, [--] engagements
"An Implantable Hypoglossal Nerve Stimulator Device Removal: Inspire Medical Systems Inc. Removes Inspire IV Implantable Pulse Generator due to Manufacturing Defect That Can Result in System Malfunctions https://www.fda.gov/medical-devices/medical-device-recalls/implantable-hypoglossal-nerve-stimulator-device-removal-inspire-medical-systems-inc-removes-inspire https://www.fda.gov/medical-devices/medical-device-recalls/implantable-hypoglossal-nerve-stimulator-device-removal-inspire-medical-systems-inc-removes-inspire"
X Link 2024-07-09T10:58Z [--] followers, [--] engagements
"PBMs Wield Enormous Power Over Patient Access to Affordable Drugs: FTC BioSpace #jobs https://www.biospace.com/article/ftc-report-finds-pharmacy-benefit-managers-wield-enormous-power-over-patient-access-to-affordable-drugs/utm_source=socialmedia https://www.biospace.com/article/ftc-report-finds-pharmacy-benefit-managers-wield-enormous-power-over-patient-access-to-affordable-drugs/utm_source=socialmedia"
X Link 2024-07-09T15:53Z [--] followers, [--] engagements
"FDA rejects Novo Nordisks weekly basal insulin https://pharmaphorum.com/news/fda-rejects-novo-nordisks-weekly-basal-insulin https://pharmaphorum.com/news/fda-rejects-novo-nordisks-weekly-basal-insulin"
X Link 2024-07-11T12:47Z [--] followers, [--] engagements
"Novo Nordisk upset as Dutch agency advises against insurance cover for Wegovy https://www.reuters.com/business/healthcare-pharmaceuticals/dutch-government-should-not-subsidise-weight-loss-drug-wegovy-adviser-says-2024-07-17/ https://www.reuters.com/business/healthcare-pharmaceuticals/dutch-government-should-not-subsidise-weight-loss-drug-wegovy-adviser-says-2024-07-17/"
X Link 2024-07-18T11:45Z [--] followers, [--] engagements
"HCL Injection (400mcg/100mL) https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-one-lot-acetaminophen-injection https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hikma-pharmaceuticals-usa-inc-extends-voluntary-nationwide-recall-one-lot-acetaminophen-injection"
X Link 2024-07-23T11:12Z [--] followers, [--] engagements
"Biopharma Layoff Tracker 2024: Pfizer Cue Anokion and More Cut Staff https://www.biospace.com/biospace-layoff-tracker https://www.biospace.com/biospace-layoff-tracker"
X Link 2024-07-31T10:04Z [--] followers, [--] engagements
"Listerine maker Kenvue beats estimates on strong essential health product sales - https://www.reuters.com/business/healthcare-pharmaceuticals/listerine-maker-kenvue-beats-estimates-strong-essential-health-product-sales-2024-08-06/ https://www.reuters.com/business/healthcare-pharmaceuticals/listerine-maker-kenvue-beats-estimates-strong-essential-health-product-sales-2024-08-06/"
X Link 2024-08-06T11:03Z [--] followers, [--] engagements
"Japanese medical equipment company to invest $398M create [---] jobs in Greenville https://www.ncbiotech.org/news/japanese-medical-equipment-company-invest-398m-create-232-jobs-greenville https://www.ncbiotech.org/news/japanese-medical-equipment-company-invest-398m-create-232-jobs-greenville"
X Link 2024-08-06T15:33Z [--] followers, [--] engagements
"Bavarian Nordic scores $157M contract to replenish US supplies of smallpox/mpox vaccine Jynneos https://www.fiercepharma.com/pharma/bavarian-nordic-scores-1568m-contract-replenish-us-supplies-combination-smallpoxmpox-vaccine https://www.fiercepharma.com/pharma/bavarian-nordic-scores-1568m-contract-replenish-us-supplies-combination-smallpoxmpox-vaccine"
X Link 2024-08-09T09:31Z [--] followers, [--] engagements
"After icodec rejection Novo Nordisk plots [----] FDA filing for once-weekly insulin and semaglutide combo https://www.fiercepharma.com/pharma/after-icodec-rejection-novo-nordisk-plots-2024-fda-filing-once-weekly-insulin-and https://www.fiercepharma.com/pharma/after-icodec-rejection-novo-nordisk-plots-2024-fda-filing-once-weekly-insulin-and"
X Link 2024-08-13T09:41Z [--] followers, [--] engagements
"Amgen sues Samsung biotech unit over bone drug copies - https://www.reuters.com/legal/litigation/amgen-sues-samsung-biotech-unit-over-bone-drug-copies-2024-08-13/ https://www.reuters.com/legal/litigation/amgen-sues-samsung-biotech-unit-over-bone-drug-copies-2024-08-13/"
X Link 2024-08-14T12:45Z [--] followers, [--] engagements
"Tandem Diabetes Care Provides Update on March [----] Nationwide Recall of t:connect Mobile App for iOS Devices https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/tandem-diabetes-care-provides-update-march-2024-nationwide-recall-tconnect-mobile-app-ios-devices https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/tandem-diabetes-care-provides-update-march-2024-nationwide-recall-tconnect-mobile-app-ios-devices"
X Link 2024-08-14T12:50Z [--] followers, [--] engagements
"Why is mpox an emergency again and how worried should I be https://www.reuters.com/business/healthcare-pharmaceuticals/why-is-mpox-an-emergency-again-how-worried-should-i-be-2024-08-15/ https://www.reuters.com/business/healthcare-pharmaceuticals/why-is-mpox-an-emergency-again-how-worried-should-i-be-2024-08-15/"
X Link 2024-08-15T10:43Z [--] followers, [--] engagements
"IRA negotiated prices revealed as Biden claims $6bn savings https://pharmaphorum.com/news/ira-negotiated-prices-revealed-biden-claims-6bn-savings https://pharmaphorum.com/news/ira-negotiated-prices-revealed-biden-claims-6bn-savings"
X Link 2024-08-16T10:11Z [--] followers, [--] engagements
"Avantor sells clinical services unit to private equity firm for $650M https://www.fiercebiotech.com/cro/avantor-sells-clinical-services-unit-private-equity-firm-650m https://www.fiercebiotech.com/cro/avantor-sells-clinical-services-unit-private-equity-firm-650m"
X Link 2024-08-20T10:30Z [--] followers, [--] engagements
"Infusion Pump Battery Correction: ICU Medical Updates Instructions for Use Regarding Batteries in Plum [---] A+ and A+3 Infusion System due to Diminished Battery Life that May Impact Infusion Delivery https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-battery-correction-icu-medical-updates-instructions-use-regarding-batteries-plum-360 https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-battery-correction-icu-medical-updates-instructions-use-regarding-batteries-plum-360"
X Link 2024-08-21T16:15Z [--] followers, [--] engagements
"Infusion Pump Battery Correction: ICU Medical Updates Instructions for Use Regarding Batteries in Plum [---] A+ and A+3 Infusion System due to Diminished Battery Life that May Impact Infusion Delivery https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-battery-correction-icu-medical-updates-instructions-use-regarding-batteries-plum-360 https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-battery-correction-icu-medical-updates-instructions-use-regarding-batteries-plum-360"
X Link 2024-08-22T11:11Z [--] followers, [--] engagements
"Cigna to Remove AbbVies Humira From Formularies Putting More Pressure on Blockbuster https://www.biospace.com/business/cigna-to-remove-abbvies-humira-from-formularies-putting-more-pressure-on-blockbuster https://www.biospace.com/business/cigna-to-remove-abbvies-humira-from-formularies-putting-more-pressure-on-blockbuster"
X Link 2024-08-27T16:19Z [--] followers, [--] engagements
"AstraZeneca investment to increase biologic capacity in Sweden https://www.europeanpharmaceuticalreview.com/news/232693/astrazeneca-investment-to-increase-biologic-capacity-in-sweden/ https://www.europeanpharmaceuticalreview.com/news/232693/astrazeneca-investment-to-increase-biologic-capacity-in-sweden/"
X Link 2024-08-28T11:19Z [--] followers, [--] engagements
"AGC Biologics Receives FDA Approval for Biosimilar at Copenhagen Facility https://www.citybuzz.co/2024/08/28/agc-biologics-receives-fda-approval-for-biosimilar-at-copenhagen-facility/ https://www.citybuzz.co/2024/08/28/agc-biologics-receives-fda-approval-for-biosimilar-at-copenhagen-facility/"
X Link 2024-08-29T11:13Z [--] followers, [--] engagements
"FDA warns consumers not to purchase or use Umary and Amazy products as they may be harmful to your health https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-umary-and-amazy-products-they-may-be-harmful-your-health https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-umary-and-amazy-products-they-may-be-harmful-your-health"
X Link 2024-09-06T10:13Z [--] followers, [--] engagements
"GSK Builds Nucalas COPD Case With Phase III Win https://www.biospace.com/drug-development/gsk-builds-nucalas-copd-case-with-phase-iii-win https://www.biospace.com/drug-development/gsk-builds-nucalas-copd-case-with-phase-iii-win"
X Link 2024-09-06T15:40Z [--] followers, [--] engagements
"Novo Nordisk experimental obesity pill has mild-to-moderate side effects in early trial https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-experimental-obesity-pill-has-mild-to-moderate-side-effects-early-2024-09-10/ https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-experimental-obesity-pill-has-mild-to-moderate-side-effects-early-2024-09-10/"
X Link 2024-09-11T10:57Z [--] followers, [--] engagements
"ESMO: AstraZeneca steps out from Daiichi's shadow posting data on ADC rivals to AbbVie Pfizer https://www.fiercebiotech.com/biotech/astrazeneca-steps-out-daiichis-shadow-posting-data-house-rivals-abbvie-and-pfizer-adcs https://www.fiercebiotech.com/biotech/astrazeneca-steps-out-daiichis-shadow-posting-data-house-rivals-abbvie-and-pfizer-adcs"
X Link 2024-09-16T10:59Z [--] followers, [--] engagements
"ICU Medical recalls tubes used in tracheostomy due to manufacturing defect https://www.reuters.com/business/healthcare-pharmaceuticals/icu-medical-recalls-tubes-used-tracheostomy-due-manufacturing-defect-2024-09-18/ https://www.reuters.com/business/healthcare-pharmaceuticals/icu-medical-recalls-tubes-used-tracheostomy-due-manufacturing-defect-2024-09-18/"
X Link 2024-09-19T10:17Z [--] followers, [--] engagements
"Pfizer pulls sickle cell med Oxbryta off market after deaths https://pharmaphorum.com/news/pfizer-pulls-sickle-cell-med-oxbryta-market-after-deaths https://pharmaphorum.com/news/pfizer-pulls-sickle-cell-med-oxbryta-market-after-deaths"
X Link 2024-09-26T09:45Z [--] followers, [--] engagements
"Slow progress on Pfizer's plan to sell drugs to low-income nations at not-for-profit price says CEO - https://www.reuters.com/business/healthcare-pharmaceuticals/slow-progress-pfizers-plan-sell-drugs-low-income-nations-not-for-profit-price-2024-09-26/ https://www.reuters.com/business/healthcare-pharmaceuticals/slow-progress-pfizers-plan-sell-drugs-low-income-nations-not-for-profit-price-2024-09-26/"
X Link 2024-09-27T09:44Z [--] followers, [--] engagements
"J&J to Invest Over $2 Billion for New Manufacturing Facility in North Carolina https://www.usnews.com/news/top-news/articles/2024-10-01/j-j-to-invest-more-than-2-billion-in-new-manufacturing-facilitysrc=usn_tw https://www.usnews.com/news/top-news/articles/2024-10-01/j-j-to-invest-more-than-2-billion-in-new-manufacturing-facilitysrc=usn_tw"
X Link 2024-10-02T09:12Z [--] followers, [--] engagements
"Big Pharma's layoff wave in New Jersey rolls on with hundreds of J&J cuts [--] at Bayer https://www.fiercepharma.com/pharma/new-jersey-johnson-johnson-cuts-231-while-bayer-axes-57 https://www.fiercepharma.com/pharma/new-jersey-johnson-johnson-cuts-231-while-bayer-axes-57"
X Link 2024-10-02T09:21Z [--] followers, [--] engagements
"BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval https://www.fiercepharma.com/pharma/bristol-myers-squibbs-opdivo-joins-perioperative-lung-cancer-treatment-ring-key-fda-approval https://www.fiercepharma.com/pharma/bristol-myers-squibbs-opdivo-joins-perioperative-lung-cancer-treatment-ring-key-fda-approval"
X Link 2024-10-04T16:06Z [--] followers, [--] engagements
"US' top IV fluid maker Baxter voices uncertainty about recovery timeline at North Carolina facility hit by Helene https://www.fiercepharma.com/pharma/us-top-iv-fluid-maker-baxter-voices-uncertainty-about-recovery-timeline-nc-facility-hit https://www.fiercepharma.com/pharma/us-top-iv-fluid-maker-baxter-voices-uncertainty-about-recovery-timeline-nc-facility-hit"
X Link 2024-10-07T16:28Z [--] followers, [--] engagements
"Warren calls on FTC to scrutinize Novo Holdings' $16.5B Catalent buyout https://www.fiercepharma.com/pharma/sen-warren-sets-sights-novo-holdings-proposed-165b-catalent-acquisition-deal-nears https://www.fiercepharma.com/pharma/sen-warren-sets-sights-novo-holdings-proposed-165b-catalent-acquisition-deal-nears"
X Link 2024-10-11T10:16Z [--] followers, [--] engagements
"Philips Respironics Issues Additional Usage Instructions for Trilogy Evo Ventilators Related to Use of In-Line Nebulizers https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/philips-respironics-issues-additional-usage-instructions-trilogy-evo-ventilators-related-use-line https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/philips-respironics-issues-additional-usage-instructions-trilogy-evo-ventilators-related-use-line"
X Link 2024-10-11T10:19Z [--] followers, [--] engagements
"Thermo Fisher plant in North Carolina flagged for contamination air bubble issues in FDA inspection https://www.fiercepharma.com/manufacturing/thermo-fishers-greenville-nc-plant-was-flagged-contamination-air-bubble-issues-fda https://www.fiercepharma.com/manufacturing/thermo-fishers-greenville-nc-plant-was-flagged-contamination-air-bubble-issues-fda"
X Link 2024-10-11T17:51Z [--] followers, [--] engagements
"Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout - https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-ceo-remain-charge-contract-drugmaker-after-novo-holdings-buyout-2024-10-21/ https://www.reuters.com/business/healthcare-pharmaceuticals/catalent-ceo-remain-charge-contract-drugmaker-after-novo-holdings-buyout-2024-10-21/"
X Link 2024-10-22T10:26Z [--] followers, [--] engagements
"Roche Beats Q3 Sales Estimates as CEO Voices Opposition to Novo Holdings Catalent Buyout https://www.biospace.com/business/roche-beats-q3-sales-estimates-as-ceo-voices-opposition-to-novo-holdings-catalent-merger https://www.biospace.com/business/roche-beats-q3-sales-estimates-as-ceo-voices-opposition-to-novo-holdings-catalent-merger"
X Link 2024-10-23T15:49Z [--] followers, [--] engagements
"AbbVie Doubles Down on Alzheimers With $1.4B Aliada Buy https://www.biospace.com/business/abbvie-doubles-down-on-alzheimers-with-1-4b-aliada-buy https://www.biospace.com/business/abbvie-doubles-down-on-alzheimers-with-1-4b-aliada-buy"
X Link 2024-10-28T15:49Z [--] followers, [--] engagements
"AbbVie to buy Alzheimer's therapy developer Aliada for $1.4 bln https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-alzheimers-therapy-developer-aliada-therapeutics-14-bln-2024-10-28/ https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-buy-alzheimers-therapy-developer-aliada-therapeutics-14-bln-2024-10-28/"
X Link 2024-10-28T15:58Z [--] followers, [--] engagements
"WuXi AppTec Remains Resilient Amid Threat from BIOSECURE Act Continues to Attract New Clients https://www.biospace.com/business/wuxi-apptec-remains-resilient-amid-threat-from-biosecure-act-continues-to-attract-new-clients https://www.biospace.com/business/wuxi-apptec-remains-resilient-amid-threat-from-biosecure-act-continues-to-attract-new-clients"
X Link 2024-10-29T15:28Z [--] followers, [---] engagements
"Update: Use of GE HealthCare EVair and EVair [--] Compressors - Letter to Health Care Providers FDA https://www.fda.gov/medical-devices/letters-health-care-providers/update-use-ge-healthcare-evair-and-evair-03-compressors-letter-health-care-providers https://www.fda.gov/medical-devices/letters-health-care-providers/update-use-ge-healthcare-evair-and-evair-03-compressors-letter-health-care-providers"
X Link 2024-10-30T10:13Z [--] followers, [--] engagements
"Key Novo Nordisk plant where Wegovy Ozempic made cited by FDA Seeking Alpha https://seekingalpha.com/news/4221254-key-novo-nordisk-plant-where-wegovy-ozempic-made-cited-by-fda https://seekingalpha.com/news/4221254-key-novo-nordisk-plant-where-wegovy-ozempic-made-cited-by-fda"
X Link 2024-10-30T10:19Z [--] followers, [--] engagements
"Incubator/Warmer Correction: GE Healthcare Updates Use Instructions for Giraffe OmniBed and Giraffe Omnibed CareStation due to Risk of Heater Door Falling and Causing Infant Injury https://www.fda.gov/medical-devices/medical-device-recalls/incubatorwarmer-correction-ge-healthcare-updates-use-instructions-giraffe-omnibed-and-giraffe https://www.fda.gov/medical-devices/medical-device-recalls/incubatorwarmer-correction-ge-healthcare-updates-use-instructions-giraffe-omnibed-and-giraffe"
X Link 2024-11-01T10:34Z [--] followers, [--] engagements
"Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis https://www.biospace.com/business/novo-nordisk-signs-285m-glp-1-deal-with-danish-neighbor-ascendis https://www.biospace.com/business/novo-nordisk-signs-285m-glp-1-deal-with-danish-neighbor-ascendis"
X Link 2024-11-04T16:50Z [--] followers, [--] engagements
"Fujifilm Diosynth Biotechnologies Launches First Phase of Expansion in Denmark https://shar.es/ag4fcx https://shar.es/ag4fcx"
X Link 2024-11-06T10:20Z [--] followers, [--] engagements
"Johnson & Johnson to invest $2B on new biologics facility in Wilson create [---] jobs https://www.ncbiotech.org/news/johnson-johnson-invest-2b-new-biologics-facility-wilson-create-420-jobs https://www.ncbiotech.org/news/johnson-johnson-invest-2b-new-biologics-facility-wilson-create-420-jobs"
X Link 2024-11-06T15:07Z [--] followers, [--] engagements
"Trump Victory a Modest Positive for Biopharma Industry: Analysts https://www.biospace.com/policy/trump-victory-a-modest-positive-for-biopharma-industry-analysts https://www.biospace.com/policy/trump-victory-a-modest-positive-for-biopharma-industry-analysts"
X Link 2024-11-06T16:29Z [--] followers, [--] engagements
"Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase [--] fail https://www.fiercebiotech.com/biotech/novo-nordisk-discards-kidney-disease-drug-13b-deal-wake-phase-3-fail https://www.fiercebiotech.com/biotech/novo-nordisk-discards-kidney-disease-drug-13b-deal-wake-phase-3-fail"
X Link 2024-11-07T11:08Z [--] followers, [--] engagements
"AbbVie Shares Plummet 12% as Cerevel Schizophrenia Asset Fails Phase II Trials https://www.biospace.com/drug-development/abbvie-shares-plummet-12-as-cerevel-schizophrenia-asset-fails-phase-ii-trials https://www.biospace.com/drug-development/abbvie-shares-plummet-12-as-cerevel-schizophrenia-asset-fails-phase-ii-trials"
X Link 2024-11-11T16:17Z [--] followers, [--] engagements
"Pfizer explores sale of hospital drugs unit amid activist investors call for accountability: Reuters https://www.fiercepharma.com/pharma/pfizer-explores-sale-hospital-drugs-unit-amid-activist-investors-call-accountability-reuters https://www.fiercepharma.com/pharma/pfizer-explores-sale-hospital-drugs-unit-amid-activist-investors-call-accountability-reuters"
X Link 2024-11-12T17:47Z [--] followers, [--] engagements
"RFK Jr vow to purge FDA sets up collision with Big Pharma https://www.reuters.com/business/healthcare-pharmaceuticals/rfk-jr-vow-purge-fda-sets-up-collision-with-big-pharma-2024-11-15/ https://www.reuters.com/business/healthcare-pharmaceuticals/rfk-jr-vow-purge-fda-sets-up-collision-with-big-pharma-2024-11-15/"
X Link 2024-11-15T12:06Z [--] followers, [--] engagements
"Hidden data on obesity prospect wipe $12B off Amgen market cap https://www.fiercebiotech.com/biotech/hidden-data-obesity-prospect-wipe-12b-amgen-market-cap https://www.fiercebiotech.com/biotech/hidden-data-obesity-prospect-wipe-12b-amgen-market-cap"
X Link 2024-11-15T12:17Z [--] followers, [--] engagements
"Top FDA vaccine official says RFK Jr. nomination is a chance for scientists to make the case for vaccines via @qz https://qz.com/fda-peter-marks-rjk-vaccines-1851705107utm_medium=sharefromsite&utm_source=quartz_twitter https://qz.com/fda-peter-marks-rjk-vaccines-1851705107utm_medium=sharefromsite&utm_source=quartz_twitter"
X Link 2024-11-22T10:51Z [--] followers, [--] engagements
"Alector's AbbVie-partnered Alzheimer's bid fails mid-stage study via @fwpharma https://firstwordpharma.com/story/5916442 https://firstwordpharma.com/story/5916442"
X Link 2024-11-26T11:48Z [--] followers, [--] engagements
"Look out Pfizer: BridgeBio scores 'best-case' FDA nod for Attruby in cardiomyopathy https://www.fiercepharma.com/pharma/comeback-story-bridgebio-scores-fda-nod-cardiomyopathy-set-take-pfizer https://www.fiercepharma.com/pharma/comeback-story-bridgebio-scores-fda-nod-cardiomyopathy-set-take-pfizer"
X Link 2024-11-26T12:02Z [--] followers, [--] engagements
"Takeda pays Keros $200M upfront for rival to BMS' booming blockbuster Reblozyl https://www.fiercebiotech.com/biotech/takeda-pays-keros-200m-upfront-rival-bms-booming-blockbuster-reblozyl https://www.fiercebiotech.com/biotech/takeda-pays-keros-200m-upfront-rival-bms-booming-blockbuster-reblozyl"
X Link 2024-12-03T17:05Z [--] followers, [--] engagements
"Reckitt shells out $200M to expand its Mucinex production site in North Carolina https://www.fiercepharma.com/manufacturing/reckitt-shells-out-200m-expand-footprint-its-nc-mucinex-production-site https://www.fiercepharma.com/manufacturing/reckitt-shells-out-200m-expand-footprint-its-nc-mucinex-production-site"
X Link 2024-12-03T17:06Z [--] followers, [--] engagements
"Amylin Commands Weight Loss Attention as Industry Anticipates Novos Phase III CagriSema Readout https://www.biospace.com/drug-development/amylin-commands-weight-loss-attention-as-industry-anticipates-novos-phase-iii-cagrisema-readout https://www.biospace.com/drug-development/amylin-commands-weight-loss-attention-as-industry-anticipates-novos-phase-iii-cagrisema-readout"
X Link 2024-12-05T11:46Z [--] followers, [---] engagements
"Syringe Recall: Cardinal Health Removes Certain Monoject U-100 mL Insulin Syringe Luer Lock with Tip Cap Soft Packs due to Incompatibility with Needleless Connectors https://www.fda.gov/medical-devices/medical-device-recalls/syringe-recall-cardinal-health-removes-certain-monoject-u-100-ml-insulin-syringe-luer-lock-tip-cap https://www.fda.gov/medical-devices/medical-device-recalls/syringe-recall-cardinal-health-removes-certain-monoject-u-100-ml-insulin-syringe-luer-lock-tip-cap"
X Link 2024-12-06T11:31Z [--] followers, [--] engagements
"A Month After Stunning Schizophrenia Fail AbbVies Other Cerevel Asset Shines Again https://www.biospace.com/drug-development/a-month-after-stunning-schizophrenia-fail-abbvies-other-cerevel-asset-shines-again https://www.biospace.com/drug-development/a-month-after-stunning-schizophrenia-fail-abbvies-other-cerevel-asset-shines-again"
X Link 2024-12-09T16:58Z [--] followers, [--] engagements
"Early Alert: Infusion Pump Issue from Fresenius Kabi USA https://www.fda.gov/medical-devices/medical-device-recalls/early-alert-infusion-pump-issue-fresenius-kabi-usa https://www.fda.gov/medical-devices/medical-device-recalls/early-alert-infusion-pump-issue-fresenius-kabi-usa"
X Link 2024-12-12T10:59Z [--] followers, [--] engagements
"AbbVie to acquire Roche spinout Nimble in immune drug deal via @BioPharmaDive https://www.biopharmadive.com/news/abbvie-nimble-acquire-deal-immune-drug-il-23/735498/ https://www.biopharmadive.com/news/abbvie-nimble-acquire-deal-immune-drug-il-23/735498/"
X Link 2024-12-13T18:02Z [--] followers, [--] engagements
"Novo Continues Manufacturing Spending Spree With $400M Denmark Expansion $200M Plant Purchase https://www.biospace.com/business/novo-continues-manufacturing-spending-spree-with-400m-denmark-expansion-200m-plant-purchase https://www.biospace.com/business/novo-continues-manufacturing-spending-spree-with-400m-denmark-expansion-200m-plant-purchase"
X Link 2024-12-16T11:39Z [--] followers, [--] engagements
"Fate of AstraZenecas Andexxa unclear as FDA rejects full approval via @fwpharma https://firstwordpharma.com/story/5921956 https://firstwordpharma.com/story/5921956"
X Link 2024-12-17T11:21Z [--] followers, [---] engagements
"Neuralink competitor Precision Neuroscience scores $102M to advance AI-powered brain implant via @fwhealthtech https://firstwordhealthtech.com/story/5921882 https://firstwordhealthtech.com/story/5921882"
X Link 2024-12-17T11:47Z [--] followers, [--] engagements
"Merck & Co. taps Chinese biotech for entry into oral GLP-1 arena via @fwpharma https://firstwordpharma.com/story/5922345 https://firstwordpharma.com/story/5922345"
X Link 2024-12-18T21:14Z [--] followers, [--] engagements
"Novo Nordisk's next-gen obesity drug CagriSema achieves lower weight loss than expected https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-next-gen-obesity-drug-cagrisema-achieves-lower-weight-loss-than-2024-12-20/ https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisks-next-gen-obesity-drug-cagrisema-achieves-lower-weight-loss-than-2024-12-20/"
X Link 2024-12-20T11:06Z [--] followers, [---] engagements
"Smart ring maker URA secures $200M to fuel AI developments via @fwhealthtech https://firstwordhealthtech.com/story/5922966 https://firstwordhealthtech.com/story/5922966"
X Link 2024-12-20T11:10Z [--] followers, [--] engagements
"Mirroring Merck's problem GSK's Jemperli-Zejula study in ovarian cancer misses survival goal https://www.fiercepharma.com/pharma/mirroring-mercks-problem-gsks-jermperli-zejula-test-ovarian-cancer-misses-survival-goal https://www.fiercepharma.com/pharma/mirroring-mercks-problem-gsks-jermperli-zejula-test-ovarian-cancer-misses-survival-goal"
X Link 2024-12-20T16:57Z [--] followers, [--] engagements
"Astellas Pharma US Inc. Issues Voluntary Nationwide Recall of One Lot of PROGRAF 0.5mg (Tacrolimus) and One Lot of ASTAGRAF XL 0.5mg (Tacrolimus Extended-Release Capsules) Because Bottles Shipped to U.S. May Contain Empty Capsules https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/astellas-pharma-us-inc-issues-voluntary-nationwide-recall-one-lot-prografr-05mg-tacrolimus-and-one https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/astellas-pharma-us-inc-issues-voluntary-nationwide-recall-one-lot-prografr-05mg-tacrolimus-and-one"
X Link 2024-12-25T13:00Z [--] followers, [--] engagements
"Calico draws blank in study of AbbVie-partnered drug for ALS via @fwpharma https://firstwordpharma.com/story/5925444 https://firstwordpharma.com/story/5925444"
X Link 2025-01-07T12:05Z [--] followers, [--] engagements
"FDA liver injury warning label for Agios' Pyrukynd The Pharmaletter https://www.thepharmaletter.com/fda-liver-injury-warning-label-for-agios-pyrukynd https://www.thepharmaletter.com/fda-liver-injury-warning-label-for-agios-pyrukynd"
X Link 2025-01-08T10:26Z [--] followers, [--] engagements
"Computing powerhouse AMD ventures into pharma via Absci partnership via @fwhealthtech https://firstwordhealthtech.com/story/5926220 https://firstwordhealthtech.com/story/5926220"
X Link 2025-01-09T11:35Z [--] followers, [--] engagements
"Humacyte gets FDA approval for bioengineered blood vessel https://www.ncbiotech.org/news/humacyte-gets-fda-approval-bioengineered-blood-vessel https://www.ncbiotech.org/news/humacyte-gets-fda-approval-bioengineered-blood-vessel"
X Link 2025-01-09T15:42Z [--] followers, [--] engagements
"New biotech Light Horse snags $1B+ Novartis pact on launch day via @fwpharma https://firstwordpharma.com/story/5926328 https://firstwordpharma.com/story/5926328"
X Link 2025-01-10T11:30Z [--] followers, [--] engagements
"HEALEY ALS Trial Serves Up More Disappointment as Denali AbbVie/Calico Fail https://www.biospace.com/drug-development/healey-als-trial-serves-up-more-disappointment-as-denali-abbvie-calico-fail https://www.biospace.com/drug-development/healey-als-trial-serves-up-more-disappointment-as-denali-abbvie-calico-fail"
X Link 2025-01-10T15:57Z [--] followers, [--] engagements
"Johnson & Johnson Makes Major Neuro Play With $14.6B Intra-Cellular Buyout https://www.biospace.com/business/johnson-johnson-makes-major-neuro-play-with-14-6b-intra-cellular-buyout https://www.biospace.com/business/johnson-johnson-makes-major-neuro-play-with-14-6b-intra-cellular-buyout"
X Link 2025-01-13T16:43Z [--] followers, [--] engagements
"Gilead Sciences US government settle patent case over HIV prevention drugs - https://www.reuters.com/legal/gilead-sciences-us-government-settle-patent-case-over-hiv-prevention-drugs-2025-01-15/ https://www.reuters.com/legal/gilead-sciences-us-government-settle-patent-case-over-hiv-prevention-drugs-2025-01-15/"
X Link 2025-01-16T12:57Z [--] followers, [--] engagements
"After delay FDA approves Amgen's Lumakras Vectibix combo for second-line CRC via @fwpharma https://firstwordpharma.com/story/5928703 https://firstwordpharma.com/story/5928703"
X Link 2025-01-17T11:42Z [--] followers, [--] engagements
"Ozempic Ibrance among next drugs picked by Medicare for price talks via @BioPharmaDive https://www.biopharmadive.com/news/medicare-drug-price-negotiations-second-round-semaglutide/736999/ https://www.biopharmadive.com/news/medicare-drug-price-negotiations-second-round-semaglutide/736999/"
X Link 2025-01-17T13:19Z [--] followers, [--] engagements
"Novo Nordisk Links High-Dose Wegovy to Increased Weight Loss in Phase III Trial https://www.biospace.com/drug-development/novo-nordisk-links-high-dose-wegovy-to-increased-weight-loss-in-phase-iii-trial https://www.biospace.com/drug-development/novo-nordisk-links-high-dose-wegovy-to-increased-weight-loss-in-phase-iii-trial"
X Link 2025-01-17T16:20Z [--] followers, [--] engagements
"McFlusion will exhibit on the [----] ISPE Facilities of the Future Conference in San Francisco on January 27-28 [----]. Connect with us at booth #408 in the Exhibit Hall. Click here to visit our online showroom: https://ispefof25.mapyourshow.com/8_0/exhibitor/exhibitor-details.cfmexhid=363602 https://ispefof25.mapyourshow.com/8_0/exhibitor/exhibitor-details.cfmexhid=363602"
X Link 2025-01-20T15:11Z [--] followers, [--] engagements
"FDA approves Johnson & Johnson nasal spray Spravato for depression https://www.cnbc.com/2025/01/21/fda-approves-johnson-johnson-nasal-spray-spravato-for-depression.html https://www.cnbc.com/2025/01/21/fda-approves-johnson-johnson-nasal-spray-spravato-for-depression.html"
X Link 2025-01-22T11:52Z [--] followers, [--] engagements
"J&J Says Deals Likely to Shrink After $14.6B Intra-Cellular Buy https://www.biospace.com/business/j-j-says-deals-likely-to-shrink-after-14-6b-intra-cellular-buy https://www.biospace.com/business/j-j-says-deals-likely-to-shrink-after-14-6b-intra-cellular-buy"
X Link 2025-01-22T16:27Z [--] followers, [--] engagements
"AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B https://www.biospace.com/business/abbvie-teams-up-with-neomorph-for-molecular-glue-collab-worth-up-to-1-64b https://www.biospace.com/business/abbvie-teams-up-with-neomorph-for-molecular-glue-collab-worth-up-to-1-64b"
X Link 2025-01-23T16:36Z [--] followers, [--] engagements
"AstraZeneca adds [---] jobs with $570M Canada investment https://www.fiercebiotech.com/biotech/astrazeneca-invests-570m-canada-expansion-adding-700-jobs https://www.fiercebiotech.com/biotech/astrazeneca-invests-570m-canada-expansion-adding-700-jobs"
X Link 2025-01-24T11:58Z [--] followers, [--] engagements
"Amgen settles Prolia patent suit with Celltrion teeing up potential biosimilar launch in June https://www.fiercepharma.com/pharma/after-sandoz-amgen-settles-patent-suit-celltrion-postponing-potential-launch-prolia-xgeva https://www.fiercepharma.com/pharma/after-sandoz-amgen-settles-patent-suit-celltrion-postponing-potential-launch-prolia-xgeva"
X Link 2025-01-29T13:35Z [--] followers, [--] engagements
"Merck & Co. says Winrevair too effective to withhold ends HYPERION study early via @fwpharma https://firstwordpharma.com/story/5931467 https://firstwordpharma.com/story/5931467"
X Link 2025-01-31T11:30Z [--] followers, [--] engagements
"AbbVie projects over $31B in Skyrizi Rinvoq sales by [----] via @fwpharma https://firstwordpharma.com/story/5931834 https://firstwordpharma.com/story/5931834"
X Link 2025-01-31T14:46Z [--] followers, [--] engagements
"Celltrion secures FDA approval for Actemra biosimilar https://www.koreabiomed.com/news/articleView.htmlidxno=26456 https://www.koreabiomed.com/news/articleView.htmlidxno=26456"
X Link 2025-02-03T12:01Z [--] followers, [--] engagements
"Merck & Co.'s pause on Gardasil shipments to China drags down outlook and shares via @fwpharma https://firstwordpharma.com/story/5932524 https://firstwordpharma.com/story/5932524"
X Link 2025-02-04T15:04Z [--] followers, [--] engagements
"Mercks Gardasil Woes Grow as China Trade War Heats Up https://www.biospace.com/business/mercks-gardasil-woes-grow-as-china-trade-war-heats-up https://www.biospace.com/business/mercks-gardasil-woes-grow-as-china-trade-war-heats-up"
X Link 2025-02-04T17:01Z [--] followers, [--] engagements
"Novo Partner Omega Waves Bankruptcy Flag from Sinking Ship https://www.biospace.com/business/novo-partner-omega-waves-bankruptcy-flag-from-sinking-ship https://www.biospace.com/business/novo-partner-omega-waves-bankruptcy-flag-from-sinking-ship"
X Link 2025-02-05T10:17Z [--] followers, [--] engagements
"Pfizer AbbVie's antibiotic FDA-approved for complicated intra-abdominal infections via @fwpharma https://firstwordpharma.com/story/5933743 https://firstwordpharma.com/story/5933743"
X Link 2025-02-10T11:48Z [--] followers, [--] engagements
"Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn https://pharmaphorum.com/news/bain-buys-japanese-pharma-mitsubishi-tanabe-34bn https://pharmaphorum.com/news/bain-buys-japanese-pharma-mitsubishi-tanabe-34bn"
X Link 2025-02-10T12:17Z [--] followers, [--] engagements
"Merck KGaA Courts Cancer Biotech SpringWorks for Potential Buyout https://www.biospace.com/business/merck-kgaa-courts-cancer-biotech-springworks-for-potential-buyout https://www.biospace.com/business/merck-kgaa-courts-cancer-biotech-springworks-for-potential-buyout"
X Link 2025-02-12T11:58Z [--] followers, [--] engagements
"AbbVie joins obesity quest with $2.3B Gubra deal via @fwpharma https://firstwordpharma.com/story/5939139 https://firstwordpharma.com/story/5939139"
X Link 2025-03-03T11:55Z [--] followers, [--] engagements
"Biohaven skids after BHV-7000 bipolar study failure via @fwpharma https://firstwordpharma.com/story/5939341 https://firstwordpharma.com/story/5939341"
X Link 2025-03-04T11:02Z [--] followers, [--] engagements
"Novo Launches DTC Program for Wegovy Cutting Price to $499 a Month https://www.biospace.com/business/novo-launches-dtc-program-for-wegovy-cutting-price-to-499-a-month https://www.biospace.com/business/novo-launches-dtc-program-for-wegovy-cutting-price-to-499-a-month"
X Link 2025-03-06T11:06Z [--] followers, [--] engagements
"Texas court decision prevents compounders from producing knockoffs of Eli Lilly's tirzepatide https://www.fiercepharma.com/pharma/texas-court-decision-prevents-compounders-producing-knockoffs-eli-lilly-tirzepatide-drugs https://www.fiercepharma.com/pharma/texas-court-decision-prevents-compounders-producing-knockoffs-eli-lilly-tirzepatide-drugs"
X Link 2025-03-07T17:23Z [--] followers, [--] engagements
"FDA reviewers inspectors and investigators excluded from $25K buyout offer https://www.raps.org/News-and-Articles/News-Articles/2025/3/FDA-reviewers-inspectors-and-investigators-exclu https://www.raps.org/News-and-Articles/News-Articles/2025/3/FDA-reviewers-inspectors-and-investigators-exclu"
X Link 2025-03-11T12:46Z [--] followers, [--] engagements
"Merck & Co. bolsters US manufacturing base with new $1B vaccine plant via @fwpharma https://firstwordpharma.com/story/5941303nle=40680&nlc=105&from=article&nlp=top-stories_position-1 https://firstwordpharma.com/story/5941303nle=40680&nlc=105&from=article&nlp=top-stories_position-1"
X Link 2025-03-12T11:20Z [--] followers, [--] engagements
"Merck & Co. moves closer to FDA filing for HIV therapy that maintains viral suppression via @fwpharma"
X Link 2025-03-13T10:57Z [--] followers, [--] engagements
"Amid Trump's push to abolish DEI Roche and Novartis adjust hiring initiatives: reports https://www.fiercepharma.com/pharma/amid-trumps-push-abolish-dei-roche-novartis-adjust-diversity-plans https://www.fiercepharma.com/pharma/amid-trumps-push-abolish-dei-roche-novartis-adjust-diversity-plans"
X Link 2025-03-20T16:29Z [--] followers, [--] engagements
"'Not a cost-cutting exercise': Novo Nordisk CSO explains rationale behind pharma's R&D shake-up https://www.fiercebiotech.com/biotech/not-cost-cutting-exercise-novo-nordisk-reshapes-rd-setup https://www.fiercebiotech.com/biotech/not-cost-cutting-exercise-novo-nordisk-reshapes-rd-setup"
X Link 2025-03-21T10:33Z [--] followers, [--] engagements
"Novartis snags FDA nod for Fabhalta in another kidney disease but leaves room for rival Apellis https://www.fiercepharma.com/pharma/novartis-snags-fda-nod-fabhalta-another-kidney-disease-leaves-room-rival-apellis https://www.fiercepharma.com/pharma/novartis-snags-fda-nod-fabhalta-another-kidney-disease-leaves-room-rival-apellis"
X Link 2025-03-21T18:14Z [--] followers, [--] engagements
"Novartis Intrathecal Zolgensma Effective in Older Children https://www.biospace.com/drug-development/Novartis-intrathecal-zolgensma-effective-in-older-children https://www.biospace.com/drug-development/Novartis-intrathecal-zolgensma-effective-in-older-children"
X Link 2025-03-24T10:10Z [--] followers, [--] engagements
"AbbVie Lawsuit Alleges That Partner Genmab "Misappropriated Trade Secrets https://www.biospace.com/business/abbvie-lawsuit-alleges-that-partner-genmab-misappropriated-trade-secrets https://www.biospace.com/business/abbvie-lawsuit-alleges-that-partner-genmab-misappropriated-trade-secrets"
X Link 2025-03-24T15:25Z [--] followers, [--] engagements
"FDA Action Alert: Amgen Aldeyra and Argenx https://www.biospace.com/fda/fda-action-alert-amgen-aldeyra-and-argenx https://www.biospace.com/fda/fda-action-alert-amgen-aldeyra-and-argenx"
X Link 2025-03-31T10:58Z [--] followers, [--] engagements
"ACC25: Merck & Co.'s Winrevair reduces mortality in most severe PAH patients via @fwpharma https://firstwordpharma.com/story/5946052 https://firstwordpharma.com/story/5946052"
X Link 2025-04-01T09:40Z [--] followers, [--] engagements
"Pfizer's sixth Flagship deal will use AI to discover autoimmune disease candidates via @fwhealthtech https://firstwordhealthtech.com/story/5946592 https://firstwordhealthtech.com/story/5946592"
X Link 2025-04-02T10:08Z [--] followers, [--] engagements
"Gubra posts early data on AbbVie-partnered obesity asset via @fwpharma https://firstwordpharma.com/story/5946649 https://firstwordpharma.com/story/5946649"
X Link 2025-04-02T10:08Z [--] followers, [--] engagements
"Eli Lilly helps struggling Sangamo with $1.4B gene therapy deal https://www.fiercebiotech.com/biotech/eli-lilly-saves-sangamo-hitting-end-cash-runway-18m-upfront-deal https://www.fiercebiotech.com/biotech/eli-lilly-saves-sangamo-hitting-end-cash-runway-18m-upfront-deal"
X Link 2025-04-04T10:00Z [--] followers, [--] engagements
"BeiGene abandons ociperlimab over poor phase [--] prospects in latest blow to TIGITs https://www.fiercebiotech.com/biotech/beigene-abandons-ociperlimab-over-poor-phase-3-prospects-latest-blow-tigits https://www.fiercebiotech.com/biotech/beigene-abandons-ociperlimab-over-poor-phase-3-prospects-latest-blow-tigits"
X Link 2025-04-04T10:01Z [--] followers, [--] engagements
"Sareptas Duchenne Gene Therapy Placed on Hold in Europe Pending Death Investigation https://www.biospace.com/drug-development/sareptas-duchenne-gene-therapy-placed-on-hold-in-europe-pending-death-investigation https://www.biospace.com/drug-development/sareptas-duchenne-gene-therapy-placed-on-hold-in-europe-pending-death-investigation"
X Link 2025-04-04T10:07Z [--] followers, [--] engagements
"Eli Lilly CEO on Trump's tariffs: 'It'll be hard to come back from here' https://www.fiercepharma.com/pharma/lilly-ceo-ricks-trumps-tariffs-itll-be-hard-come-back-here https://www.fiercepharma.com/pharma/lilly-ceo-ricks-trumps-tariffs-itll-be-hard-come-back-here"
X Link 2025-04-04T17:00Z [--] followers, [--] engagements
"Novo Nordisk plugs more than $1B into upgrade of Brazilian manufacturing operations for injectable drugs including GLP-1s https://www.fiercepharma.com/manufacturing/novo-nordisk-plugs-more-1b-upgrade-brazilian-manufacturing-operations-injectable https://www.fiercepharma.com/manufacturing/novo-nordisk-plugs-more-1b-upgrade-brazilian-manufacturing-operations-injectable"
X Link 2025-04-08T17:38Z [--] followers, [--] engagements
"Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs via @investopedia https://www.investopedia.com/novartis-plans-usd23b-investment-in-us-facilities-as-trump-threatens-pharma-tariffs-11713217utm_source=social2&utm_medium=social&utm_campaign=shareurlbuttons https://www.investopedia.com/novartis-plans-usd23b-investment-in-us-facilities-as-trump-threatens-pharma-tariffs-11713217utm_source=social2&utm_medium=social&utm_campaign=shareurlbuttons"
X Link 2025-04-15T10:34Z [--] followers, [--] engagements
"White House launches national security investigation into pharma semiconductors https://thehill.com/policy/healthcare/5248629-white-house-pharma-semiconductor-tariffs/ https://thehill.com/policy/healthcare/5248629-white-house-pharma-semiconductor-tariffs/"
X Link 2025-04-15T10:36Z [--] followers, [--] engagements
"FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain FDA https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain"
X Link 2025-04-15T10:41Z [--] followers, [--] engagements
"Merck inks $493M biobucks deal to use Cyprumed's tech to create oral peptides https://www.fiercebiotech.com/biotech/merck-looks-leverage-cyprumeds-oral-drug-delivery-platform-its-peptides-493m-deal https://www.fiercebiotech.com/biotech/merck-looks-leverage-cyprumeds-oral-drug-delivery-platform-its-peptides-493m-deal"
X Link 2025-04-16T09:38Z [--] followers, [--] engagements
"Novartis pulls plug on Phase II knee osteoarthritis treatment via @fwpharma https://firstwordpharma.com/story/5950339 https://firstwordpharma.com/story/5950339"
X Link 2025-04-17T10:25Z [--] followers, [--] engagements
"Lilly's oral GLP-1 succeeds in first Phase III test via @fwpharma https://firstwordpharma.com/story/5950404 https://firstwordpharma.com/story/5950404"
X Link 2025-04-17T13:23Z [--] followers, [--] engagements
"EU authorizes Eisai-Biogen's drug for early Alzheimer's treatment - https://www.reuters.com/business/healthcare-pharmaceuticals/eu-authorizes-eisai-biogens-drug-treatment-early-alzheimers-disease-2025-04-15/ https://www.reuters.com/business/healthcare-pharmaceuticals/eu-authorizes-eisai-biogens-drug-treatment-early-alzheimers-disease-2025-04-15/"
X Link 2025-04-18T10:37Z [--] followers, [--] engagements
"Eli Lilly is overtaking Novo Nordisk in the diabetes obesity market: BMO analysts https://www.fiercepharma.com/pharma/eli-lilly-overtaking-novo-nordisk-diabetesobesity-market-analysts https://www.fiercepharma.com/pharma/eli-lilly-overtaking-novo-nordisk-diabetesobesity-market-analysts"
X Link 2025-04-18T16:13Z [--] followers, [--] engagements
"Amid industry's onshoring push Regeneron taps Fujifilm Diosynth for $3B 10-year commercial manufacturing team-up https://www.fiercepharma.com/manufacturing/amid-industry-onshoring-push-regeneron-taps-fujifilm-diosynth-3b-10-year-commercial https://www.fiercepharma.com/manufacturing/amid-industry-onshoring-push-regeneron-taps-fujifilm-diosynth-3b-10-year-commercial"
X Link 2025-04-22T16:04Z [--] followers, [--] engagements
"Boehringer to expand oncology presence with $572m Tessellate Bio deal via @PharmaTechFocus https://www.pharmaceutical-technology.com/news/boehringer-to-expand-oncology-presence-with-572m-tessellate-bio-deal/ https://www.pharmaceutical-technology.com/news/boehringer-to-expand-oncology-presence-with-572m-tessellate-bio-deal/"
X Link 2025-04-24T10:43Z [--] followers, [--] engagements
"Merck & Co.'s injectable Keytruda triggers patent lawsuit from Halozyme via @fwpharma https://firstwordpharma.com/story/5952473 https://firstwordpharma.com/story/5952473"
X Link 2025-04-25T10:33Z [--] followers, [--] engagements
"Merck & Co. maintains full-year projections while warning of tariff hit via @fwpharma https://firstwordpharma.com/story/5952668 https://firstwordpharma.com/story/5952668"
X Link 2025-04-25T10:34Z [--] followers, [--] engagements
"Thermo Fisher To Invest Addl. $2 Bln In U.S. To Boost Manufacturing Nasdaq https://www.rttnews.com/3531422/thermo-fisher-to-invest-addl-2-bln-in-u-s-to-boost-manufacturing.aspx https://www.rttnews.com/3531422/thermo-fisher-to-invest-addl-2-bln-in-u-s-to-boost-manufacturing.aspx"
X Link 2025-04-25T10:37Z [--] followers, [--] engagements
"PCI Pharma Services to Acquire Ajinomoto Althea https://www.contractpharma.com/breaking-news/pci-pharma-services-to-acquire-ajinomoto-althea/ https://www.contractpharma.com/breaking-news/pci-pharma-services-to-acquire-ajinomoto-althea/"
X Link 2025-04-25T10:41Z [--] followers, [--] engagements
"Summit Akesos Keytruda Challenger Wins Chinese OK as US Approval Questions Linger https://www.biospace.com/drug-development/summit-akesos-keytruda-challenger-wins-chinese-ok-as-us-approval-questions-linger https://www.biospace.com/drug-development/summit-akesos-keytruda-challenger-wins-chinese-ok-as-us-approval-questions-linger"
X Link 2025-04-28T21:24Z [--] followers, [--] engagements
"Dutch biotech emerges with $50M plug-and-play antibody engineering platform via @fwpharma https://firstwordpharma.com/story/5952551 https://firstwordpharma.com/story/5952551"
X Link 2025-04-29T06:10Z [--] followers, [--] engagements
"Novo moves past GLP-1 spat with Hims & Hers tapping telehealth company to offer discounted Wegovy https://www.fiercepharma.com/pharma/novo-moves-past-glp-1-spat-hims-tapping-telehealth-companies-offer-low-cost-wegovy https://www.fiercepharma.com/pharma/novo-moves-past-glp-1-spat-hims-tapping-telehealth-companies-offer-low-cost-wegovy"
X Link 2025-04-29T16:48Z [--] followers, [--] engagements
"Samsung Biologics inks $518M production contract with US pharma extending CDMO's dealmaking streak https://www.fiercepharma.com/manufacturing/samsung-biologics-production-streak-continues-518m-us-pharma-contract https://www.fiercepharma.com/manufacturing/samsung-biologics-production-streak-continues-518m-us-pharma-contract"
X Link 2025-05-02T06:05Z [--] followers, [--] engagements
"RFK Jr. to require placebo-controlled studies for new vaccines : Shots - Health News : NPR https://www.npr.org/sections/shots-health-news/2025/05/01/nx-s1-5383172/rfk-jr-placebo-vaccine-testing-studies https://www.npr.org/sections/shots-health-news/2025/05/01/nx-s1-5383172/rfk-jr-placebo-vaccine-testing-studies"
X Link 2025-05-02T06:07Z [--] followers, [--] engagements
"In major blow for Lilly Novo strikes deal giving Wegovy preferred access on CVS Caremark formulary https://www.fiercepharma.com/pharma/major-blow-lilly-novo-strikes-deal-giving-wegovy-preferred-access-cvs-caremark-formulary https://www.fiercepharma.com/pharma/major-blow-lilly-novo-strikes-deal-giving-wegovy-preferred-access-cvs-caremark-formulary"
X Link 2025-05-02T18:51Z [--] followers, [--] engagements
"Vertex discontinues AAV vector research for gene therapies https://www.fiercebiotech.com/biotech/vertex-discontinues-aav-vector-research-gene-therapies https://www.fiercebiotech.com/biotech/vertex-discontinues-aav-vector-research-gene-therapies"
X Link 2025-05-05T10:17Z [--] followers, [--] engagements
"BREAKING: White House Releases Budget Proposal Slashing HHS Agencies https://hcinnovationgroup.com/policy-value-based-care/article/55287780/breaking-white-house-releases-budget-proposal-slashing-hhs-agencies https://hcinnovationgroup.com/policy-value-based-care/article/55287780/breaking-white-house-releases-budget-proposal-slashing-hhs-agencies"
X Link 2025-05-05T10:18Z [--] followers, [--] engagements
"FDA accepts filing application for oral semaglutide [--] mg which if approved would be the first oral GLP-1 treatment for obesity https://www.prnewswire.com/news-releases/fda-accepts-filing-application-for-oral-semaglutide-25-mg-which-if-approved-would-be-the-first-oral-glp-1-treatment-for-obesity-302445232.html https://www.prnewswire.com/news-releases/fda-accepts-filing-application-for-oral-semaglutide-25-mg-which-if-approved-would-be-the-first-oral-glp-1-treatment-for-obesity-302445232.html"
X Link 2025-05-05T10:20Z [--] followers, [--] engagements
"PTC's Novartis-partnered Huntington's drug disappoints in mid-stage data reveal via @fwpharma https://firstwordpharma.com/story/5956490 https://firstwordpharma.com/story/5956490"
X Link 2025-05-06T10:44Z [--] followers, [--] engagements
"OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation WIRED https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/ https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/"
X Link 2025-05-08T10:08Z [--] followers, [--] engagements
"FDA eyes full AI integration by June as Makary touts genAI pilot success via @fwhealthtech https://firstwordhealthtech.com/story/5958730 https://firstwordhealthtech.com/story/5958730"
X Link 2025-05-09T09:39Z [--] followers, [--] engagements
"Citing tariffs Illumina slashes guidance confirms SEC's Grail investigation is closed via @fwhealthtech https://firstwordhealthtech.com/story/5959070 https://firstwordhealthtech.com/story/5959070"
X Link 2025-05-09T09:53Z [--] followers, [--] engagements
"Lilly touts more Zepbound data from head-to-head Wegovy trial via @fwpharma https://firstwordpharma.com/story/5959568 https://firstwordpharma.com/story/5959568"
X Link 2025-05-12T10:25Z [--] followers, [--] engagements
"AbbVie plant workers in Ireland threaten to strike over pay dispute: reports https://www.fiercepharma.com/manufacturing/abbvie-plant-workers-ireland-threaten-strike-over-pay-dispute https://www.fiercepharma.com/manufacturing/abbvie-plant-workers-ireland-threaten-strike-over-pay-dispute"
X Link 2025-05-14T16:52Z [--] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing